{"pair_id":"AIMed.d146.s1235.p0","sentence":"To determine the role of each of these receptors in @PROTEIN1$ driven proliferation, @PROTEIN2$ expression and proliferative capacity were monitored during mitogenic stimulation.","label":0}
{"pair_id":"AIMed.d157.s1329.p0","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, @PROTEIN1$ (@PROTEIN2$), binds AKAP79 at a site distinct from those bound by PKA or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p1","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, @PROTEIN1$ (PKC), binds @PROTEIN2$ at a site distinct from those bound by PKA or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p2","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, @PROTEIN1$ (PKC), binds AKAP79 at a site distinct from those bound by @PROTEIN2$ or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p3","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, @PROTEIN1$ (PKC), binds AKAP79 at a site distinct from those bound by PKA or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d157.s1329.p4","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (@PROTEIN1$), binds @PROTEIN2$ at a site distinct from those bound by PKA or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p5","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (@PROTEIN1$), binds AKAP79 at a site distinct from those bound by @PROTEIN2$ or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p6","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (@PROTEIN1$), binds AKAP79 at a site distinct from those bound by PKA or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d157.s1329.p7","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (PKC), binds @PROTEIN1$ at a site distinct from those bound by @PROTEIN2$ or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p8","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (PKC), binds @PROTEIN1$ at a site distinct from those bound by PKA or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d157.s1329.p9","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (PKC), binds AKAP79 at a site distinct from those bound by @PROTEIN1$ or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d214.s1.p0","sentence":"Our data strongly support the view that the mobile form of @PROTEIN1$ in slow transport is soluble and that a substantial amount of this actin may travel as a complex with @PROTEIN2$, cofilin, and profilin.","label":0}
{"pair_id":"BioInfer.d214.s1.p1","sentence":"Our data strongly support the view that the mobile form of @PROTEIN1$ in slow transport is soluble and that a substantial amount of this @PROTEIN2$ may travel as a complex with actin depolymerizing factor, cofilin, and profilin.","label":0}
{"pair_id":"BioInfer.d214.s1.p2","sentence":"Our data strongly support the view that the mobile form of @PROTEIN1$ in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, @PROTEIN2$, and profilin.","label":0}
{"pair_id":"BioInfer.d214.s1.p3","sentence":"Our data strongly support the view that the mobile form of @PROTEIN1$ in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d214.s1.p4","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this @PROTEIN2$ may travel as a complex with @PROTEIN1$, cofilin, and profilin.","label":1}
{"pair_id":"BioInfer.d214.s1.p5","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with @PROTEIN1$, @PROTEIN2$, and profilin.","label":1}
{"pair_id":"BioInfer.d214.s1.p6","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with @PROTEIN1$, cofilin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d214.s1.p7","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this @PROTEIN1$ may travel as a complex with actin depolymerizing factor, @PROTEIN2$, and profilin.","label":1}
{"pair_id":"BioInfer.d214.s1.p8","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this @PROTEIN1$ may travel as a complex with actin depolymerizing factor, cofilin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d214.s1.p9","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, @PROTEIN1$, and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d158.s1337.p0","sentence":"However, expression of the death domain of @PROTEIN1$ Induces apoptosis, but potently inhibits @PROTEIN2$ activation by TNF.","label":0}
{"pair_id":"BioInfer.d396.s0.p0","sentence":"It reduced the rate of @PROTEIN2$ polymerization as reported in the cases of @PROTEIN1$ from other organisms.","label":0}
{"pair_id":"BioInfer.d181.s0.p0","sentence":"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors @PROTEIN1$ and @PROTEIN2$ increased, whereas expression of cyclin D1 decreased.","label":0}
{"pair_id":"BioInfer.d181.s0.p1","sentence":"During apoptotic process induced by the agents, expression of @PROTEIN2$ @PROTEIN1$ and p27 increased, whereas expression of cyclin D1 decreased.","label":1}
{"pair_id":"BioInfer.d181.s0.p2","sentence":"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors @PROTEIN1$ and p27 increased, whereas expression of @PROTEIN2$ decreased.","label":0}
{"pair_id":"BioInfer.d181.s0.p3","sentence":"During apoptotic process induced by the agents, expression of @PROTEIN2$ p21 and @PROTEIN1$ increased, whereas expression of cyclin D1 decreased.","label":1}
{"pair_id":"BioInfer.d181.s0.p4","sentence":"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and @PROTEIN1$ increased, whereas expression of @PROTEIN2$ decreased.","label":0}
{"pair_id":"BioInfer.d181.s0.p5","sentence":"During apoptotic process induced by the agents, expression of @PROTEIN1$ p21 and p27 increased, whereas expression of @PROTEIN2$ decreased.","label":0}
{"pair_id":"AIMed.d16.s137.p0","sentence":"Expressions of @PROTEIN1$, @PROTEIN2$ and GCH were detected by Western blot analysis.","label":0}
{"pair_id":"AIMed.d16.s137.p1","sentence":"Expressions of @PROTEIN1$, AADC and @PROTEIN2$ were detected by Western blot analysis.","label":0}
{"pair_id":"AIMed.d16.s137.p2","sentence":"Expressions of TH, @PROTEIN1$ and @PROTEIN2$ were detected by Western blot analysis.","label":0}
{"pair_id":"BioInfer.d652.s0.p0","sentence":"The N-terminal @PROTEIN1$ polypeptide eventually disrupted @PROTEIN2$ stress fibres whereas the C-terminal polypeptide was without effect.","label":1}
{"pair_id":"BioInfer.d350.s0.p0","sentence":"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the @PROTEIN1$ p27, which blocks the activating effects of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d350.s0.p1","sentence":"In order to help explain the apparent beneficial effects of @PROTEIN2$ over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the @PROTEIN1$ p27, which blocks the activating effects of cyclin D1.","label":0}
{"pair_id":"BioInfer.d350.s0.p2","sentence":"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the @PROTEIN1$ @PROTEIN2$, which blocks the activating effects of cyclin D1.","label":1}
{"pair_id":"BioInfer.d350.s0.p3","sentence":"In order to help explain the apparent beneficial effects of @PROTEIN2$ over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d350.s0.p4","sentence":"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor @PROTEIN2$, which blocks the activating effects of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d350.s0.p5","sentence":"In order to help explain the apparent beneficial effects of @PROTEIN1$ over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor @PROTEIN2$, which blocks the activating effects of cyclin D1.","label":0}
{"pair_id":"AIMed.d185.s1576.p0","sentence":"In contrast, tyrosine-phosphorylated peptides containing Tyr374 or Tyr396 did not interact with @PROTEIN1$ or block @PROTEIN2$ activation.","label":0}
{"pair_id":"AIMed.d103.s871.p0","sentence":"We show that @PROTEIN1$ interacts with @PROTEIN2$ both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.","label":1}
{"pair_id":"AIMed.d103.s871.p1","sentence":"We show that @PROTEIN1$ interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, @PROTEIN2$ also interacts directly with TBP.","label":0}
{"pair_id":"AIMed.d103.s871.p2","sentence":"We show that @PROTEIN1$ interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s871.p3","sentence":"We show that hTAFII28 interacts with @PROTEIN1$ both in vitro and intracellularly; in contrast to its Drosophila homologue, @PROTEIN2$ also interacts directly with TBP.","label":0}
{"pair_id":"AIMed.d103.s871.p4","sentence":"We show that hTAFII28 interacts with @PROTEIN1$ both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d103.s871.p5","sentence":"We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, @PROTEIN1$ also interacts directly with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d120.s1013.p0","sentence":"Specific binding of the transglutaminase, @PROTEIN1$, to @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d254.s0.p0","sentence":"Here, we show that the x-ray sensitivity of rad55 and @PROTEIN1$ mutant strains is suppressible by overexpression of @PROTEIN2$ or RAD52.","label":0}
{"pair_id":"BioInfer.d254.s0.p1","sentence":"Here, we show that the x-ray sensitivity of @PROTEIN2$ and @PROTEIN1$ mutant strains is suppressible by overexpression of RAD51 or RAD52.","label":0}
{"pair_id":"BioInfer.d254.s0.p2","sentence":"Here, we show that the x-ray sensitivity of rad55 and @PROTEIN1$ mutant strains is suppressible by overexpression of RAD51 or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d254.s0.p3","sentence":"Here, we show that the x-ray sensitivity of @PROTEIN2$ and rad57 mutant strains is suppressible by overexpression of @PROTEIN1$ or RAD52.","label":0}
{"pair_id":"BioInfer.d254.s0.p4","sentence":"Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of @PROTEIN1$ or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d254.s0.p5","sentence":"Here, we show that the x-ray sensitivity of @PROTEIN1$ and rad57 mutant strains is suppressible by overexpression of RAD51 or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d27.s229.p0","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as @PROTEIN1$ and @PROTEIN2$ and regulators of apoptosis such as p53 and members of the bcl-2 family.","label":0}
{"pair_id":"AIMed.d27.s229.p1","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as @PROTEIN1$ and p21 and regulators of apoptosis such as @PROTEIN2$ and members of the bcl-2 family.","label":0}
{"pair_id":"AIMed.d27.s229.p2","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as @PROTEIN1$ and p21 and regulators of apoptosis such as p53 and members of the @PROTEIN2$ family.","label":0}
{"pair_id":"AIMed.d27.s229.p3","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and @PROTEIN1$ and regulators of apoptosis such as @PROTEIN2$ and members of the bcl-2 family.","label":0}
{"pair_id":"AIMed.d27.s229.p4","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and @PROTEIN1$ and regulators of apoptosis such as p53 and members of the @PROTEIN2$ family.","label":0}
{"pair_id":"AIMed.d27.s229.p5","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as @PROTEIN1$ and members of the @PROTEIN2$ family.","label":0}
{"pair_id":"AIMed.d61.s532.p0","sentence":"An expression plasmid encoding the human 75-kDa @PROTEIN1$ (@PROTEIN2$) was constructed and used to generate a stable human cell line (293\/TNF-R2) overexpressing TNF-R2.","label":0}
{"pair_id":"AIMed.d61.s532.p1","sentence":"An expression plasmid encoding the human 75-kDa @PROTEIN1$ (TNF-R2) was constructed and used to generate a stable human cell line (293\/@PROTEIN2$) overexpressing TNF-R2.","label":0}
{"pair_id":"AIMed.d61.s532.p2","sentence":"An expression plasmid encoding the human 75-kDa @PROTEIN1$ (TNF-R2) was constructed and used to generate a stable human cell line (293\/TNF-R2) overexpressing @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d61.s532.p3","sentence":"An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (@PROTEIN1$) was constructed and used to generate a stable human cell line (293\/@PROTEIN2$) overexpressing TNF-R2.","label":0}
{"pair_id":"AIMed.d61.s532.p4","sentence":"An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (@PROTEIN1$) was constructed and used to generate a stable human cell line (293\/TNF-R2) overexpressing @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d61.s532.p5","sentence":"An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293\/@PROTEIN1$) overexpressing @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d190.s1618.p0","sentence":"Moreover we found that, upon @PROTEIN1$ stimulation, the @PROTEIN2$\/c-Cbl complex recruits Shc, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p1","sentence":"Moreover we found that, upon @PROTEIN1$ stimulation, the Grb2\/@PROTEIN2$ complex recruits Shc, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p2","sentence":"Moreover we found that, upon @PROTEIN1$ stimulation, the Grb2\/c-Cbl complex recruits @PROTEIN2$, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p3","sentence":"Moreover we found that, upon @PROTEIN1$ stimulation, the Grb2\/c-Cbl complex recruits Shc, probably via @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d190.s1618.p4","sentence":"Moreover we found that, upon SCF stimulation, the @PROTEIN1$\/@PROTEIN2$ complex recruits Shc, probably via Grb2.","label":1}
{"pair_id":"AIMed.d190.s1618.p5","sentence":"Moreover we found that, upon SCF stimulation, the @PROTEIN1$\/c-Cbl complex recruits @PROTEIN2$, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p6","sentence":"Moreover we found that, upon SCF stimulation, the @PROTEIN1$\/c-Cbl complex recruits Shc, probably via @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d190.s1618.p7","sentence":"Moreover we found that, upon SCF stimulation, the Grb2\/@PROTEIN1$ complex recruits @PROTEIN2$, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p8","sentence":"Moreover we found that, upon SCF stimulation, the Grb2\/@PROTEIN1$ complex recruits Shc, probably via @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d190.s1618.p9","sentence":"Moreover we found that, upon SCF stimulation, the Grb2\/c-Cbl complex recruits @PROTEIN1$, probably via @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d263.s1.p0","sentence":"In contrast, overexpression of the profilin gene, @PROTEIN2$, encoding an @PROTEIN1$, leads to no very obvious phenotype.","label":1}
{"pair_id":"BioInfer.d263.s1.p1","sentence":"In contrast, overexpression of the @PROTEIN2$ gene, PFY1, encoding an @PROTEIN1$, leads to no very obvious phenotype.","label":1}
{"pair_id":"BioInfer.d263.s1.p2","sentence":"In contrast, overexpression of the @PROTEIN2$ gene, @PROTEIN1$, encoding an actin-binding protein, leads to no very obvious phenotype.","label":0}
{"pair_id":"AIMed.d25.s204.p0","sentence":"The objective of this study was to measure the concentrations of @PROTEIN1$ (@PROTEIN2$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p1","sentence":"The objective of this study was to measure the concentrations of @PROTEIN1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether @PROTEIN2$, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p2","sentence":"The objective of this study was to measure the concentrations of @PROTEIN1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, @PROTEIN2$ (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p3","sentence":"The objective of this study was to measure the concentrations of @PROTEIN1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (@PROTEIN2$), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p4","sentence":"The objective of this study was to measure the concentrations of @PROTEIN1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors @PROTEIN2$ and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p5","sentence":"The objective of this study was to measure the concentrations of @PROTEIN1$ (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and @PROTEIN2$ can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p6","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (@PROTEIN1$) in pleural and peritoneal effusions of different causes and to verify whether @PROTEIN2$, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p7","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (@PROTEIN1$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, @PROTEIN2$ (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p8","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (@PROTEIN1$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (@PROTEIN2$), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p9","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (@PROTEIN1$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors @PROTEIN2$ and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p10","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (@PROTEIN1$) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and @PROTEIN2$ can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p11","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether @PROTEIN1$, @PROTEIN2$ (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p12","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether @PROTEIN1$, alpha-1-antitrypsin (@PROTEIN2$), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p13","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether @PROTEIN1$, alpha-1-antitrypsin (alpha1AT), and complement factors @PROTEIN2$ and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p14","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether @PROTEIN1$, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and @PROTEIN2$ can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p15","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, @PROTEIN1$ (@PROTEIN2$), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p16","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, @PROTEIN1$ (alpha1AT), and complement factors @PROTEIN2$ and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p17","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, @PROTEIN1$ (alpha1AT), and complement factors C3 and @PROTEIN2$ can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p18","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (@PROTEIN1$), and complement factors @PROTEIN2$ and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p19","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (@PROTEIN1$), and complement factors C3 and @PROTEIN2$ can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p20","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors @PROTEIN1$ and @PROTEIN2$ can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"BioInfer.d465.s1.p0","sentence":"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of @PROTEIN1$ (@PROTEIN2$) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p1","sentence":"We observed that four replication proteins, UL5, UL8 UL52, and @PROTEIN2$, are necessary for the localization of @PROTEIN1$ (UL29) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p2","sentence":"We observed that four replication proteins, UL5, UL8 @PROTEIN2$, and UL9, are necessary for the localization of @PROTEIN1$ (UL29) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p3","sentence":"We observed that four replication proteins, UL5, @PROTEIN2$ UL52, and UL9, are necessary for the localization of @PROTEIN1$ (UL29) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p4","sentence":"We observed that four replication proteins, @PROTEIN2$, UL8 UL52, and UL9, are necessary for the localization of @PROTEIN1$ (UL29) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p5","sentence":"We observed that four replication proteins, UL5, UL8 UL52, and @PROTEIN2$, are necessary for the localization of ICP8 (@PROTEIN1$) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p6","sentence":"We observed that four replication proteins, UL5, UL8 @PROTEIN2$, and UL9, are necessary for the localization of ICP8 (@PROTEIN1$) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p7","sentence":"We observed that four replication proteins, UL5, @PROTEIN2$ UL52, and UL9, are necessary for the localization of ICP8 (@PROTEIN1$) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p8","sentence":"We observed that four replication proteins, @PROTEIN2$, UL8 UL52, and UL9, are necessary for the localization of ICP8 (@PROTEIN1$) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p9","sentence":"We observed that four replication proteins, UL5, UL8 @PROTEIN2$, and @PROTEIN1$, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p10","sentence":"We observed that four replication proteins, UL5, @PROTEIN2$ UL52, and @PROTEIN1$, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p11","sentence":"We observed that four replication proteins, @PROTEIN2$, UL8 UL52, and @PROTEIN1$, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p12","sentence":"We observed that four replication proteins, UL5, @PROTEIN2$ @PROTEIN1$, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p13","sentence":"We observed that four replication proteins, @PROTEIN2$, UL8 @PROTEIN1$, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p14","sentence":"We observed that four replication proteins, @PROTEIN2$, @PROTEIN1$ UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"AIMed.d15.s131.p0","sentence":"@PROTEIN1$, @PROTEIN2$ and IL-10 levels were statistically greater in patients.","label":0}
{"pair_id":"AIMed.d15.s131.p1","sentence":"@PROTEIN1$, IL-2 and @PROTEIN2$ levels were statistically greater in patients.","label":0}
{"pair_id":"AIMed.d15.s131.p2","sentence":"Interferon-gamma, @PROTEIN1$ and @PROTEIN2$ levels were statistically greater in patients.","label":0}
{"pair_id":"AIMed.d16.s136.p0","sentence":"METHODS: The genes for dopamine synthetic enzymes, @PROTEIN1$ (@PROTEIN2$), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p1","sentence":"METHODS: The genes for dopamine synthetic enzymes, @PROTEIN1$ (TH), @PROTEIN2$ (AADC), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p2","sentence":"METHODS: The genes for dopamine synthetic enzymes, @PROTEIN1$ (TH), aromatic L-amino acid decarboxylase (@PROTEIN2$), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p3","sentence":"METHODS: The genes for dopamine synthetic enzymes, @PROTEIN1$ (TH), aromatic L-amino acid decarboxylase (AADC), and @PROTEIN2$ (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p4","sentence":"METHODS: The genes for dopamine synthetic enzymes, @PROTEIN1$ (TH), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I (@PROTEIN2$, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p5","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (@PROTEIN1$), @PROTEIN2$ (AADC), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p6","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (@PROTEIN1$), aromatic L-amino acid decarboxylase (@PROTEIN2$), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p7","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (@PROTEIN1$), aromatic L-amino acid decarboxylase (AADC), and @PROTEIN2$ (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p8","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (@PROTEIN1$), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I (@PROTEIN2$, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p9","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), @PROTEIN1$ (@PROTEIN2$), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p10","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), @PROTEIN1$ (AADC), and @PROTEIN2$ (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p11","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), @PROTEIN1$ (AADC), and GTP cyclohydrolase I (@PROTEIN2$, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p12","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (@PROTEIN1$), and @PROTEIN2$ (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p13","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (@PROTEIN1$), and GTP cyclohydrolase I (@PROTEIN2$, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p14","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (AADC), and @PROTEIN1$ (@PROTEIN2$, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"BioInfer.d43.s0.p0","sentence":"Although co-localization of @PROTEIN2$ with @PROTEIN1$ filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, islet glucokinase was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.","label":1}
{"pair_id":"BioInfer.d43.s0.p1","sentence":"Although co-localization of glucokinase with @PROTEIN1$ filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, @PROTEIN2$ was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.","label":0}
{"pair_id":"BioInfer.d43.s0.p2","sentence":"Although co-localization of @PROTEIN1$ with actin filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, @PROTEIN2$ was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.","label":0}
{"pair_id":"BioInfer.d279.s1.p0","sentence":"In cultured cells, cofilin, as well as @PROTEIN1$, translocates from the cytoplasm into the nucleus together with @PROTEIN2$ and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.","label":1}
{"pair_id":"BioInfer.d279.s1.p1","sentence":"In cultured cells, @PROTEIN2$, as well as @PROTEIN1$, translocates from the cytoplasm into the nucleus together with actin and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.","label":0}
{"pair_id":"BioInfer.d279.s1.p2","sentence":"In cultured cells, @PROTEIN2$, as well as ADF, translocates from the cytoplasm into the nucleus together with @PROTEIN1$ and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.","label":1}
{"pair_id":"AIMed.d57.s504.p0","sentence":"A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (@PROTEIN1$) has been used here to form complexes between the @PROTEIN2$ tyrosine kinase and hsp90.","label":0}
{"pair_id":"AIMed.d57.s504.p1","sentence":"A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (@PROTEIN1$) has been used here to form complexes between the pp60src tyrosine kinase and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d57.s504.p2","sentence":"A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (hsp90) has been used here to form complexes between the @PROTEIN1$ tyrosine kinase and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d138.s1170.p0","sentence":"Furthermore, the 60-kilodalton subunit of @PROTEIN1$ is related to the yeast splicing protein @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d14.s118.p0","sentence":"Correlations between @PROTEIN1$ and @PROTEIN2$ in CSF as markers for astrogliosis and neurodegeneration, and clinical and biological data were investigated.","label":0}
{"pair_id":"BioInfer.d333.s0.p0","sentence":"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive @PROTEIN1$ and sarcomeric myosin heavy chain (@PROTEIN2$) normally seen after serum withdrawal.","label":0}
{"pair_id":"BioInfer.d333.s0.p1","sentence":"In enriched cell lines and in a pure myocyte cell strain, @PROTEIN2$ inhibited increases in immunoreactive @PROTEIN1$ and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.","label":1}
{"pair_id":"BioInfer.d333.s0.p2","sentence":"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive @PROTEIN1$ and @PROTEIN2$ (SMHC) normally seen after serum withdrawal.","label":0}
{"pair_id":"BioInfer.d333.s0.p3","sentence":"In enriched cell lines and in a pure myocyte cell strain, @PROTEIN2$ inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (@PROTEIN1$) normally seen after serum withdrawal.","label":1}
{"pair_id":"BioInfer.d333.s0.p4","sentence":"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and @PROTEIN2$ (@PROTEIN1$) normally seen after serum withdrawal.","label":0}
{"pair_id":"BioInfer.d333.s0.p5","sentence":"In enriched cell lines and in a pure myocyte cell strain, @PROTEIN1$ inhibited increases in immunoreactive sarcomeric actin and @PROTEIN2$ (SMHC) normally seen after serum withdrawal.","label":1}
{"pair_id":"AIMed.d48.s422.p0","sentence":"We report chemotaxis and competitive binding studies that show @PROTEIN1$ binds to and activates @PROTEIN2$ and CCR8 transfected HEK-293 cells.","label":1}
{"pair_id":"AIMed.d48.s422.p1","sentence":"We report chemotaxis and competitive binding studies that show @PROTEIN1$ binds to and activates CCR1 and @PROTEIN2$ transfected HEK-293 cells.","label":1}
{"pair_id":"AIMed.d48.s422.p2","sentence":"We report chemotaxis and competitive binding studies that show LEC binds to and activates @PROTEIN1$ and @PROTEIN2$ transfected HEK-293 cells.","label":0}
{"pair_id":"AIMed.d57.s505.p0","sentence":"Reticulocyte lysate forms complexes between @PROTEIN1$ and a temperature-sensitive mutant of Rous sarcoma virus @PROTEIN2$, which is normally present in cytosol virtually entirely in the multiprotein complex form.","label":1}
{"pair_id":"AIMed.d180.s1536.p0","sentence":"Surprisingly, the N-terminal third of @PROTEIN1$ alone bound @PROTEIN2$ more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.","label":1}
{"pair_id":"AIMed.d180.s1536.p1","sentence":"Surprisingly, the N-terminal third of @PROTEIN1$ alone bound CaM more strongly than did intact @PROTEIN2$, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.","label":0}
{"pair_id":"AIMed.d180.s1536.p2","sentence":"Surprisingly, the N-terminal third of @PROTEIN1$ alone bound CaM more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d180.s1536.p3","sentence":"Surprisingly, the N-terminal third of GAP-43 alone bound @PROTEIN1$ more strongly than did intact @PROTEIN2$, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.","label":1}
{"pair_id":"AIMed.d180.s1536.p4","sentence":"Surprisingly, the N-terminal third of GAP-43 alone bound @PROTEIN1$ more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d180.s1536.p5","sentence":"Surprisingly, the N-terminal third of GAP-43 alone bound CaM more strongly than did intact @PROTEIN1$, suggesting that the protein's C-terminus may play a role in modulating the interaction with @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d151.s1288.p0","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the @PROTEIN1$ (@PROTEIN2$) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p1","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the @PROTEIN1$ (TBP) with @PROTEIN2$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p2","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the @PROTEIN1$ (TBP) with PTF, consistent with the previous report of a @PROTEIN2$-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p3","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the @PROTEIN1$ (TBP) with PTF, consistent with the previous report of a PTF-related complex (@PROTEIN2$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p4","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the @PROTEIN1$ (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of @PROTEIN2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p5","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the @PROTEIN1$ (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (@PROTEIN2$) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p6","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the @PROTEIN1$ (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the @PROTEIN2$ gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p7","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (@PROTEIN1$) with @PROTEIN2$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p8","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (@PROTEIN1$) with PTF, consistent with the previous report of a @PROTEIN2$-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p9","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (@PROTEIN1$) with PTF, consistent with the previous report of a PTF-related complex (@PROTEIN2$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p10","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (@PROTEIN1$) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of @PROTEIN2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p11","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (@PROTEIN1$) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (@PROTEIN2$) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p12","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (@PROTEIN1$) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the @PROTEIN2$ gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p13","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with @PROTEIN1$, consistent with the previous report of a @PROTEIN2$-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p14","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with @PROTEIN1$, consistent with the previous report of a PTF-related complex (@PROTEIN2$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p15","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with @PROTEIN1$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of @PROTEIN2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p16","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with @PROTEIN1$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (@PROTEIN2$) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p17","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with @PROTEIN1$, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the @PROTEIN2$ gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p18","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a @PROTEIN1$-related complex (@PROTEIN2$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p19","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a @PROTEIN1$-related complex (SNAPc) containing substoichiometric levels of @PROTEIN2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p20","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a @PROTEIN1$-related complex (SNAPc) containing substoichiometric levels of TBP and a component (@PROTEIN2$) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p21","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a @PROTEIN1$-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the @PROTEIN2$ gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p22","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (@PROTEIN1$) containing substoichiometric levels of @PROTEIN2$ and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p23","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (@PROTEIN1$) containing substoichiometric levels of TBP and a component (@PROTEIN2$) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p24","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (@PROTEIN1$) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the @PROTEIN2$ gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p25","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of @PROTEIN1$ and a component (@PROTEIN2$) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p26","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of @PROTEIN1$ and a component (SNAPc43) identical in sequence to the @PROTEIN2$ gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p27","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (@PROTEIN1$) identical in sequence to the @PROTEIN2$ gamma reported here.","label":0}
{"pair_id":"AIMed.d119.s1007.p0","sentence":"@PROTEIN1$ is activated through phosphorylation by @PROTEIN2$ (PKA), but precisely how phosphorylation stimulates CREB function is unknown.","label":1}
{"pair_id":"AIMed.d119.s1007.p1","sentence":"@PROTEIN1$ is activated through phosphorylation by protein kinase A (@PROTEIN2$), but precisely how phosphorylation stimulates CREB function is unknown.","label":1}
{"pair_id":"AIMed.d119.s1007.p2","sentence":"@PROTEIN1$ is activated through phosphorylation by protein kinase A (PKA), but precisely how phosphorylation stimulates @PROTEIN2$ function is unknown.","label":0}
{"pair_id":"AIMed.d119.s1007.p3","sentence":"CREB is activated through phosphorylation by @PROTEIN1$ (@PROTEIN2$), but precisely how phosphorylation stimulates CREB function is unknown.","label":0}
{"pair_id":"AIMed.d119.s1007.p4","sentence":"CREB is activated through phosphorylation by @PROTEIN1$ (PKA), but precisely how phosphorylation stimulates @PROTEIN2$ function is unknown.","label":0}
{"pair_id":"AIMed.d119.s1007.p5","sentence":"CREB is activated through phosphorylation by protein kinase A (@PROTEIN1$), but precisely how phosphorylation stimulates @PROTEIN2$ function is unknown.","label":0}
{"pair_id":"BioInfer.d358.s0.p0","sentence":"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein @PROTEIN1$ by @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d358.s0.p1","sentence":"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of @PROTEIN2$ or cleavage of linking protein @PROTEIN1$ by calpain.","label":0}
{"pair_id":"BioInfer.d358.s0.p2","sentence":"@PROTEIN2$ binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein @PROTEIN1$ by calpain.","label":0}
{"pair_id":"BioInfer.d358.s0.p3","sentence":"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of @PROTEIN2$ or cleavage of linking protein talin by @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d358.s0.p4","sentence":"@PROTEIN2$ binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d358.s0.p5","sentence":"@PROTEIN2$ binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of @PROTEIN1$ or cleavage of linking protein talin by calpain.","label":0}
{"pair_id":"AIMed.d71.s603.p0","sentence":"The proto-oncogene @PROTEIN1$ is a component of the @PROTEIN2$ transcription factor family involved in the mediation of nuclear events elicited by extracellular stimuli.","label":0}
{"pair_id":"BioInfer.d169.s0.p0","sentence":"Depending on the nature of the divalent cation, recombinant plant (birch) @PROTEIN2$ exhibited two different modes of interaction with @PROTEIN1$, like mammalian profilin.","label":1}
{"pair_id":"BioInfer.d169.s0.p1","sentence":"Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with @PROTEIN1$, like mammalian @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d169.s0.p2","sentence":"Depending on the nature of the divalent cation, recombinant plant (birch) @PROTEIN1$ exhibited two different modes of interaction with actin, like mammalian @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d209.s1812.p0","sentence":"This @PROTEIN1$ sequence shows preferential binding to the @PROTEIN2$ domain in vitro.","label":1}
{"pair_id":"BioInfer.d183.s1.p0","sentence":"The distribution of @PROTEIN1$ filaments is altered by @PROTEIN2$ overexpression.","label":1}
{"pair_id":"BioInfer.d418.s0.p0","sentence":"Membranous staining and concomitant cytoplasmic localization of E-cadherin, @PROTEIN2$ and @PROTEIN1$ were seen in one case with abnormal beta-catenin immunoreactivity.","label":1}
{"pair_id":"BioInfer.d418.s0.p1","sentence":"Membranous staining and concomitant cytoplasmic localization of @PROTEIN2$, alpha-catenin and @PROTEIN1$ were seen in one case with abnormal beta-catenin immunoreactivity.","label":1}
{"pair_id":"BioInfer.d418.s0.p2","sentence":"Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and @PROTEIN1$ were seen in one case with abnormal @PROTEIN2$ immunoreactivity.","label":0}
{"pair_id":"BioInfer.d418.s0.p3","sentence":"Membranous staining and concomitant cytoplasmic localization of @PROTEIN2$, @PROTEIN1$ and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.","label":1}
{"pair_id":"BioInfer.d418.s0.p4","sentence":"Membranous staining and concomitant cytoplasmic localization of E-cadherin, @PROTEIN1$ and gamma-catenin were seen in one case with abnormal @PROTEIN2$ immunoreactivity.","label":0}
{"pair_id":"BioInfer.d418.s0.p5","sentence":"Membranous staining and concomitant cytoplasmic localization of @PROTEIN1$, alpha-catenin and gamma-catenin were seen in one case with abnormal @PROTEIN2$ immunoreactivity.","label":0}
{"pair_id":"AIMed.d87.s740.p0","sentence":"This activation with @PROTEIN1$ and @PROTEIN2$ beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p1","sentence":"This activation with @PROTEIN1$ and @PROTEIN2$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":1}
{"pair_id":"AIMed.d87.s740.p2","sentence":"This activation with @PROTEIN1$ and IGF-1R beta was 4-fold less as compared to @PROTEIN2$ and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":1}
{"pair_id":"AIMed.d87.s740.p3","sentence":"This activation with @PROTEIN1$ and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN2$ beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p4","sentence":"This activation with @PROTEIN1$ and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN2$ (delta C-43).","label":1}
{"pair_id":"AIMed.d87.s740.p5","sentence":"This activation with @PROTEIN1$ and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (@PROTEIN2$3).","label":0}
{"pair_id":"AIMed.d87.s740.p6","sentence":"This activation with p85 and @PROTEIN1$@PROTEIN2$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p7","sentence":"This activation with p85 and @PROTEIN1$ beta was 4-fold less as compared to @PROTEIN2$ and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p8","sentence":"This activation with p85 and @PROTEIN1$ beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN2$ beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p9","sentence":"This activation with p85 and @PROTEIN1$ beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN2$ (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p10","sentence":"This activation with p85 and @PROTEIN1$ beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (@PROTEIN2$3).","label":0}
{"pair_id":"AIMed.d87.s740.p11","sentence":"This activation with p85 and @PROTEIN1$ was 4-fold less as compared to @PROTEIN2$ and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p12","sentence":"This activation with p85 and @PROTEIN1$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN2$ beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p13","sentence":"This activation with p85 and @PROTEIN1$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN2$ (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p14","sentence":"This activation with p85 and @PROTEIN1$ was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (@PROTEIN2$3).","label":0}
{"pair_id":"AIMed.d87.s740.p15","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to @PROTEIN1$ and was somewhat increased (2-fold) for @PROTEIN2$ beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p16","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to @PROTEIN1$ and was somewhat increased (2-fold) for @PROTEIN2$ (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p17","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to @PROTEIN1$ and was somewhat increased (2-fold) for IGF-1R beta (@PROTEIN2$3).","label":0}
{"pair_id":"AIMed.d87.s740.p18","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN1$@PROTEIN2$ (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p19","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN1$ beta (@PROTEIN2$3).","label":0}
{"pair_id":"AIMed.d87.s740.p20","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for @PROTEIN1$ (@PROTEIN2$3).","label":0}
{"pair_id":"BioInfer.d467.s0.p0","sentence":"On the other hand, we have recently proposed the importance of @PROTEIN2$, an @PROTEIN1$-binding phosphoprotein, in phagocyte functions through dephosphorylation and translocation to the plasma membrane regions.","label":1}
{"pair_id":"BioInfer.d232.s0.p0","sentence":"Genetic dissection of Drosophila myofibril formation: effects of @PROTEIN1$ and @PROTEIN2$ null alleles.","label":0}
{"pair_id":"AIMed.d96.s813.p0","sentence":"In vitro binding studies demonstrated that the intracellular segment of @PROTEIN1$ binds directly to the intracellular domain of @PROTEIN2$, but not to alpha- or beta-catenin.","label":1}
{"pair_id":"AIMed.d96.s813.p1","sentence":"In vitro binding studies demonstrated that the intracellular segment of @PROTEIN1$ binds directly to the intracellular domain of E-cadherin, but not to alpha- or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d96.s813.p2","sentence":"In vitro binding studies demonstrated that the intracellular segment of PTPmu binds directly to the intracellular domain of @PROTEIN1$, but not to alpha- or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d176.s1486.p0","sentence":"In the present study we observe that a monoclonal antibody specific for @PROTEIN1$ can, on the one hand, inhibit formation of mature @PROTEIN2$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p1","sentence":"In the present study we observe that a monoclonal antibody specific for @PROTEIN1$ can, on the one hand, inhibit formation of mature PR complexes containing @PROTEIN2$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p2","sentence":"In the present study we observe that a monoclonal antibody specific for @PROTEIN1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (@PROTEIN2$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p3","sentence":"In the present study we observe that a monoclonal antibody specific for @PROTEIN1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), @PROTEIN2$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p4","sentence":"In the present study we observe that a monoclonal antibody specific for @PROTEIN1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early @PROTEIN2$ complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p5","sentence":"In the present study we observe that a monoclonal antibody specific for @PROTEIN1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing @PROTEIN2$ and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p6","sentence":"In the present study we observe that a monoclonal antibody specific for @PROTEIN1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and @PROTEIN2$ (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p7","sentence":"In the present study we observe that a monoclonal antibody specific for @PROTEIN1$ can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d176.s1486.p8","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature @PROTEIN1$ complexes containing @PROTEIN2$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p9","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature @PROTEIN1$ complexes containing heat shock protein 90 (@PROTEIN2$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p10","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature @PROTEIN1$ complexes containing heat shock protein 90 (hsp90), @PROTEIN2$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p11","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature @PROTEIN1$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early @PROTEIN2$ complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p12","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature @PROTEIN1$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing @PROTEIN2$ and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p13","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature @PROTEIN1$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and @PROTEIN2$ (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p14","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature @PROTEIN1$ complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d176.s1486.p15","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing @PROTEIN1$ (@PROTEIN2$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p16","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing @PROTEIN1$ (hsp90), @PROTEIN2$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p17","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing @PROTEIN1$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early @PROTEIN2$ complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p18","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing @PROTEIN1$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing @PROTEIN2$ and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p19","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing @PROTEIN1$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and @PROTEIN2$ (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p20","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing @PROTEIN1$ (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d176.s1486.p21","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (@PROTEIN1$), @PROTEIN2$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p22","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (@PROTEIN1$), p23, and immunophilins and, on the other, enhance recovery of early @PROTEIN2$ complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p23","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (@PROTEIN1$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing @PROTEIN2$ and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p24","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (@PROTEIN1$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and @PROTEIN2$ (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p25","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (@PROTEIN1$), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d176.s1486.p26","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), @PROTEIN1$, and immunophilins and, on the other, enhance recovery of early @PROTEIN2$ complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p27","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), @PROTEIN1$, and immunophilins and, on the other, enhance recovery of early PR complexes containing @PROTEIN2$ and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p28","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), @PROTEIN1$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and @PROTEIN2$ (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p29","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), @PROTEIN1$, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d176.s1486.p30","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early @PROTEIN1$ complexes containing @PROTEIN2$ and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p31","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early @PROTEIN1$ complexes containing hsp70 and @PROTEIN2$ (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p32","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early @PROTEIN1$ complexes containing hsp70 and Hip (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d176.s1486.p33","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing @PROTEIN1$ and @PROTEIN2$ (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p34","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing @PROTEIN1$ and Hip (@PROTEIN2$).","label":0}
{"pair_id":"AIMed.d176.s1486.p35","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and @PROTEIN1$ (@PROTEIN2$).","label":0}
{"pair_id":"BioInfer.d293.s0.p0","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for @PROTEIN2$ and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for @PROTEIN1$ and nonmuscle myosin heavy chain II-B.","label":0}
{"pair_id":"BioInfer.d293.s0.p1","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d293.s0.p2","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and @PROTEIN2$ and a weak to moderate reactivity of a lesser number of cells for @PROTEIN1$ and nonmuscle myosin heavy chain II-B.","label":0}
{"pair_id":"BioInfer.d293.s0.p3","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for @PROTEIN1$ and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d293.s0.p4","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for @PROTEIN1$ and @PROTEIN2$ and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.","label":0}
{"pair_id":"BioInfer.d293.s0.p5","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and @PROTEIN2$ and a weak to moderate reactivity of a lesser number of cells for desmin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d61.s0.p0","sentence":"Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d61.s0.p1","sentence":"Analysis of various truncated @PROTEIN2$ molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d61.s0.p2","sentence":"Analysis of various truncated @PROTEIN2$ molecules revealed that amino-terminal residues 48-163 are able to bind to @PROTEIN1$ and plakoglobin.","label":1}
{"pair_id":"BioInfer.d33.s2.p0","sentence":"MATERIALS AND METHODS: We used an @PROTEIN1$-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, @PROTEIN2$, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p1","sentence":"MATERIALS AND METHODS: We used an @PROTEIN1$-biotin immunoperoxidase technique to examine the cellular localization of @PROTEIN2$, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p2","sentence":"MATERIALS AND METHODS: We used an @PROTEIN1$-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and @PROTEIN2$ in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p3","sentence":"MATERIALS AND METHODS: We used an @PROTEIN1$-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, @PROTEIN2$ and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p4","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of @PROTEIN2$, @PROTEIN1$, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p5","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, @PROTEIN1$, gamma-catenin and @PROTEIN2$ in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p6","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, @PROTEIN1$, @PROTEIN2$ and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p7","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of @PROTEIN1$, beta-catenin, gamma-catenin and @PROTEIN2$ in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p8","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of @PROTEIN1$, beta-catenin, @PROTEIN2$ and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p9","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, @PROTEIN2$ and @PROTEIN1$ in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"AIMed.d0.s5.p0","sentence":"Cytokines measurements during @PROTEIN1$ treatment showed a trend to decreasing levels of @PROTEIN2$ at 4, 12, and 24 weeks.","label":0}
{"pair_id":"AIMed.d222.s1931.p0","sentence":"The screen identified interactions involving @PROTEIN1$ and two 14-3-3 isoforms, @PROTEIN2$, human unconventional myosin IC, and a recently identified SH3 domain containing protein, SH3 P17.","label":1}
{"pair_id":"AIMed.d222.s1931.p1","sentence":"The screen identified interactions involving @PROTEIN1$ and two 14-3-3 isoforms, cytokeratin 18, human unconventional myosin IC, and a recently identified SH3 domain containing protein, @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d222.s1931.p2","sentence":"The screen identified interactions involving c-Cbl and two 14-3-3 isoforms, @PROTEIN1$, human unconventional myosin IC, and a recently identified SH3 domain containing protein, @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d121.s1031.p0","sentence":"These mutations have no impact on the ability of the @PROTEIN1$ protein to bind to a @PROTEIN2$-specific DNA element.","label":0}
{"pair_id":"AIMed.d182.s1545.p0","sentence":"Structure of the @PROTEIN1$ oncoprotein bound to the @PROTEIN2$ tumor suppressor transactivation domain.","label":1}
{"pair_id":"BioInfer.d792.s0.p0","sentence":"@PROTEIN2$, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding @PROTEIN1$, an actin-regulatory protein that stimulates actin filament assembly.","label":1}
{"pair_id":"BioInfer.d792.s0.p1","sentence":"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding @PROTEIN1$, an @PROTEIN2$-regulatory protein that stimulates actin filament assembly.","label":1}
{"pair_id":"BioInfer.d792.s0.p2","sentence":"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding @PROTEIN1$, an actin-regulatory protein that stimulates @PROTEIN2$ filament assembly.","label":1}
{"pair_id":"BioInfer.d792.s0.p3","sentence":"@PROTEIN1$, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an @PROTEIN2$-regulatory protein that stimulates actin filament assembly.","label":0}
{"pair_id":"BioInfer.d792.s0.p4","sentence":"@PROTEIN1$, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates @PROTEIN2$ filament assembly.","label":0}
{"pair_id":"BioInfer.d792.s0.p5","sentence":"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an @PROTEIN1$-regulatory protein that stimulates @PROTEIN2$ filament assembly.","label":0}
{"pair_id":"BioInfer.d288.s2.p0","sentence":"The NH2-terminal 16kD of @PROTEIN1$, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d288.s2.p1","sentence":"The NH2-terminal 16kD of @PROTEIN1$, a 65-kD yeast protein identified by its ability to bind to @PROTEIN2$ filaments, is 23% identical to yeast cofilin.","label":1}
{"pair_id":"BioInfer.d288.s2.p2","sentence":"The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to @PROTEIN2$ filaments, is 23% identical to yeast @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d497.s1.p0","sentence":"The @PROTEIN1$ @PROTEIN2$ binds to PIP2 and inhibits its hydrolysis by phospholipase C.","label":1}
{"pair_id":"BioInfer.d497.s1.p1","sentence":"The @PROTEIN1$ profilin binds to PIP2 and inhibits its hydrolysis by @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d497.s1.p2","sentence":"The actin-binding protein @PROTEIN1$ binds to PIP2 and inhibits its hydrolysis by @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d190.s1612.p0","sentence":"In the present study we evaluated tyrosine phosphorylation of @PROTEIN1$ and the interaction of the @PROTEIN2$\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p1","sentence":"In the present study we evaluated tyrosine phosphorylation of @PROTEIN1$ and the interaction of the Grb2\/@PROTEIN2$ complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p2","sentence":"In the present study we evaluated tyrosine phosphorylation of @PROTEIN1$ and the interaction of the Grb2\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (@PROTEIN2$) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p3","sentence":"In the present study we evaluated tyrosine phosphorylation of @PROTEIN1$ and the interaction of the Grb2\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (@PROTEIN2$) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p4","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the @PROTEIN1$\/@PROTEIN2$ complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":1}
{"pair_id":"AIMed.d190.s1612.p5","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the @PROTEIN1$\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (@PROTEIN2$) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p6","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the @PROTEIN1$\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (@PROTEIN2$) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p7","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2\/@PROTEIN1$ complex with signaling proteins upon activation of non-tyrosine (@PROTEIN2$) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p8","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2\/@PROTEIN1$ complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (@PROTEIN2$) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p9","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (@PROTEIN1$) and tyrosine kinase (@PROTEIN2$) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"BioInfer.d398.s1.p0","sentence":"The data suggest that profilin binding to @PROTEIN2$ weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the @PROTEIN1$ central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p1","sentence":"The data suggest that profilin binding to actin weakens nucleotide binding to @PROTEIN2$ by disrupting Mg(2+) coordination in the @PROTEIN1$ central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p2","sentence":"The data suggest that @PROTEIN2$ binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the @PROTEIN1$ central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p3","sentence":"The data suggest that profilin binding to @PROTEIN1$ weakens nucleotide binding to @PROTEIN2$ by disrupting Mg(2+) coordination in the actin central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p4","sentence":"The data suggest that @PROTEIN2$ binding to @PROTEIN1$ weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p5","sentence":"The data suggest that @PROTEIN2$ binding to actin weakens nucleotide binding to @PROTEIN1$ by disrupting Mg(2+) coordination in the actin central cleft.","label":1}
{"pair_id":"BioInfer.d3.s1.p0","sentence":"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, @PROTEIN1$, and @PROTEIN2$ at the neuromuscular synapse.","label":0}
{"pair_id":"BioInfer.d3.s1.p1","sentence":"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of @PROTEIN2$, @PROTEIN1$, and acetylcholinesterase at the neuromuscular synapse.","label":0}
{"pair_id":"BioInfer.d3.s1.p2","sentence":"Thus, @PROTEIN2$ has an important role in synapse formation and in the organization of utrophin, @PROTEIN1$, and acetylcholinesterase at the neuromuscular synapse.","label":1}
{"pair_id":"BioInfer.d3.s1.p3","sentence":"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of @PROTEIN2$, acetylcholine receptor, and @PROTEIN1$ at the neuromuscular synapse.","label":0}
{"pair_id":"BioInfer.d3.s1.p4","sentence":"Thus, @PROTEIN2$ has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and @PROTEIN1$ at the neuromuscular synapse.","label":1}
{"pair_id":"BioInfer.d3.s1.p5","sentence":"Thus, @PROTEIN2$ has an important role in synapse formation and in the organization of @PROTEIN1$, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.","label":1}
{"pair_id":"BioInfer.d65.s0.p0","sentence":"An oligomeric form of simian virus 40 @PROTEIN1$ is immunologically related to the cellular tumor antigen @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d117.s0.p0","sentence":"By 1 h the cells were well spread with straight @PROTEIN2$ bundles many of which ended at more central sites terminating on patches containing vinculin and @PROTEIN1$; thus the cells assemble typical stress fibers but do not appear to polarize.","label":0}
{"pair_id":"BioInfer.d117.s0.p1","sentence":"By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing @PROTEIN2$ and @PROTEIN1$; thus the cells assemble typical stress fibers but do not appear to polarize.","label":1}
{"pair_id":"BioInfer.d117.s0.p2","sentence":"By 1 h the cells were well spread with straight @PROTEIN1$ bundles many of which ended at more central sites terminating on patches containing @PROTEIN2$ and talin; thus the cells assemble typical stress fibers but do not appear to polarize.","label":0}
{"pair_id":"BioInfer.d471.s0.p0","sentence":"Other than monomeric @PROTEIN1$, no major @PROTEIN2$ ligands are detected in crude extracts.","label":1}
{"pair_id":"BioInfer.d57.s0.p0","sentence":"Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the @PROTEIN2$ (sple, @PROTEIN2$) which appears to regulate the interaction with @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d57.s0.p1","sentence":"Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the @PROTEIN2$ (@PROTEIN2$, splee) which appears to regulate the interaction with @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d57.s0.p2","sentence":"Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the @PROTEIN1$@PROTEIN2$ (@PROTEIN2$, @PROTEIN1$) which appears to regulate the interaction with profilin.","label":0}
{"pair_id":"AIMed.d32.s271.p0","sentence":"We used alanine substitution of @PROTEIN1$ residues that contact @PROTEIN2$ in the crystal structure to investigate the function of these residues in both EMP1 and EPO binding.","label":1}
{"pair_id":"AIMed.d32.s271.p1","sentence":"We used alanine substitution of @PROTEIN1$ residues that contact EMP1 in the crystal structure to investigate the function of these residues in both @PROTEIN2$ and EPO binding.","label":1}
{"pair_id":"AIMed.d32.s271.p2","sentence":"We used alanine substitution of @PROTEIN1$ residues that contact EMP1 in the crystal structure to investigate the function of these residues in both EMP1 and @PROTEIN2$ binding.","label":1}
{"pair_id":"AIMed.d32.s271.p3","sentence":"We used alanine substitution of EBP residues that contact @PROTEIN1$ in the crystal structure to investigate the function of these residues in both @PROTEIN2$ and EPO binding.","label":0}
{"pair_id":"AIMed.d32.s271.p4","sentence":"We used alanine substitution of EBP residues that contact @PROTEIN1$ in the crystal structure to investigate the function of these residues in both EMP1 and @PROTEIN2$ binding.","label":0}
{"pair_id":"AIMed.d32.s271.p5","sentence":"We used alanine substitution of EBP residues that contact EMP1 in the crystal structure to investigate the function of these residues in both @PROTEIN1$ and @PROTEIN2$ binding.","label":0}
{"pair_id":"BioInfer.d214.s2.p0","sentence":"We examined the axonal transport of @PROTEIN2$ and its monomer binding proteins, actin depolymerizing factor, cofilin, and @PROTEIN1$, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":1}
{"pair_id":"BioInfer.d214.s2.p1","sentence":"We examined the axonal transport of actin and its monomer binding proteins, @PROTEIN2$, cofilin, and @PROTEIN1$, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":0}
{"pair_id":"BioInfer.d214.s2.p2","sentence":"We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, @PROTEIN2$, and @PROTEIN1$, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":0}
{"pair_id":"BioInfer.d214.s2.p3","sentence":"We examined the axonal transport of @PROTEIN1$ and its monomer binding proteins, @PROTEIN2$, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":1}
{"pair_id":"BioInfer.d214.s2.p4","sentence":"We examined the axonal transport of @PROTEIN1$ and its monomer binding proteins, actin depolymerizing factor, @PROTEIN2$, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":1}
{"pair_id":"BioInfer.d214.s2.p5","sentence":"We examined the axonal transport of actin and its monomer binding proteins, @PROTEIN1$, @PROTEIN2$, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":0}
{"pair_id":"AIMed.d207.s1793.p0","sentence":"In differentiating C2C12 cells, @PROTEIN1$ complexes switch and DNA synthesis in response to serum are prevented when @PROTEIN2$ DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p1","sentence":"In differentiating C2C12 cells, @PROTEIN1$ complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor @PROTEIN2$ downstream effector p21 are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p2","sentence":"In differentiating C2C12 cells, @PROTEIN1$ complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector @PROTEIN2$ are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p3","sentence":"In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when @PROTEIN1$ DNA binding activity and the cdks inhibitor @PROTEIN2$ downstream effector p21 are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p4","sentence":"In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when @PROTEIN1$ DNA binding activity and the cdks inhibitor MyoD downstream effector @PROTEIN2$ are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p5","sentence":"In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor @PROTEIN1$ downstream effector @PROTEIN2$ are induced.","label":0}
{"pair_id":"AIMed.d183.s1558.p0","sentence":"In addition, @PROTEIN1$ phosphorylated @PROTEIN2$ at sites different from those phosphorylated by pp60v-src.","label":1}
{"pair_id":"AIMed.d183.s1558.p1","sentence":"In addition, @PROTEIN1$ phosphorylated Raf-1 at sites different from those phosphorylated by @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d183.s1558.p2","sentence":"In addition, JAK2 phosphorylated @PROTEIN1$ at sites different from those phosphorylated by @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d650.s0.p0","sentence":"The mutants ranged in affinity, from those that only weakly affected polymerization of @PROTEIN2$ to one that bound actin more strongly than wild-type @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d650.s0.p1","sentence":"The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound @PROTEIN2$ more strongly than wild-type @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d650.s0.p2","sentence":"The mutants ranged in affinity, from those that only weakly affected polymerization of @PROTEIN1$ to one that bound @PROTEIN2$ more strongly than wild-type profilin.","label":0}
{"pair_id":"BioInfer.d104.s0.p0","sentence":"MSH3 appears to be more closely related to the mouse @PROTEIN1$ gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other @PROTEIN2$ homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p1","sentence":"MSH3 appears to be more closely related to the mouse @PROTEIN1$ gene and other similar eukaryotic @PROTEIN2$ homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p2","sentence":"@PROTEIN2$ appears to be more closely related to the mouse @PROTEIN1$ gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.","label":1}
{"pair_id":"BioInfer.d104.s0.p3","sentence":"MSH3 appears to be more closely related to the mouse @PROTEIN1$ gene and other similar eukaryotic mutS homologues than to the yeast gene @PROTEIN2$ and other mutS homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p4","sentence":"MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic @PROTEIN2$ homologues than to the yeast gene MSH2 and other @PROTEIN1$ homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p5","sentence":"@PROTEIN2$ appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other @PROTEIN1$ homologues that are involved in replication repair.","label":1}
{"pair_id":"BioInfer.d104.s0.p6","sentence":"MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene @PROTEIN2$ and other @PROTEIN1$ homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p7","sentence":"@PROTEIN2$ appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic @PROTEIN1$ homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.","label":1}
{"pair_id":"BioInfer.d104.s0.p8","sentence":"MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic @PROTEIN1$ homologues than to the yeast gene @PROTEIN2$ and other mutS homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p9","sentence":"@PROTEIN1$ appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene @PROTEIN2$ and other mutS homologues that are involved in replication repair.","label":1}
{"pair_id":"AIMed.d193.s1647.p0","sentence":"Further investigation indicated that the @PROTEIN1$\/@PROTEIN2$ heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3\/HLH462.","label":1}
{"pair_id":"AIMed.d193.s1647.p1","sentence":"Further investigation indicated that the @PROTEIN1$\/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by @PROTEIN2$\/HLH462.","label":0}
{"pair_id":"AIMed.d193.s1647.p2","sentence":"Further investigation indicated that the @PROTEIN1$\/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d193.s1647.p3","sentence":"Further investigation indicated that the ITF-2b\/@PROTEIN1$ heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by @PROTEIN2$\/HLH462.","label":0}
{"pair_id":"AIMed.d193.s1647.p4","sentence":"Further investigation indicated that the ITF-2b\/@PROTEIN1$ heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d193.s1647.p5","sentence":"Further investigation indicated that the ITF-2b\/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by @PROTEIN1$\/@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d167.s1409.p0","sentence":"A @PROTEIN1$ mutant that was not glycosylated (AGGT155) did not associate with @PROTEIN2$ or CAP-60.","label":0}
{"pair_id":"AIMed.d167.s1409.p1","sentence":"A @PROTEIN1$ mutant that was not glycosylated (AGGT155) did not associate with calnexin or @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d167.s1409.p2","sentence":"A GT155 mutant that was not glycosylated (AGGT155) did not associate with @PROTEIN1$ or @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d155.s0.p0","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of @PROTEIN1$ binds beta-catenin and plakoglobin, and can form a structural complex with @PROTEIN2$ via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p1","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of @PROTEIN1$ binds @PROTEIN2$ and plakoglobin, and can form a structural complex with E-cadherin via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p2","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of @PROTEIN1$ binds beta-catenin and @PROTEIN2$, and can form a structural complex with E-cadherin via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p3","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds @PROTEIN2$ and plakoglobin, and can form a structural complex with @PROTEIN1$ via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p4","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and @PROTEIN2$, and can form a structural complex with @PROTEIN1$ via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p5","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds @PROTEIN1$ and @PROTEIN2$, and can form a structural complex with E-cadherin via these interactions.","label":0}
{"pair_id":"AIMed.d150.s1281.p0","sentence":"These results demonstrate that @PROTEIN1$ interacts specifically with a lineage-restricted @PROTEIN2$ transcription factor.","label":0}
{"pair_id":"BioInfer.d627.s0.p0","sentence":"The influence of these @PROTEIN1$ on cell morphology and the distribution pattern of actin, @PROTEIN2$, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":1}
{"pair_id":"BioInfer.d627.s0.p1","sentence":"The influence of these @PROTEIN1$ on cell morphology and the distribution pattern of @PROTEIN2$, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":1}
{"pair_id":"BioInfer.d627.s0.p2","sentence":"The influence of these @PROTEIN1$ on cell morphology and the distribution pattern of actin, vimentin, talin, and @PROTEIN2$ was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":1}
{"pair_id":"BioInfer.d627.s0.p3","sentence":"The influence of these @PROTEIN1$ on cell morphology and the distribution pattern of actin, vimentin, @PROTEIN2$, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":1}
{"pair_id":"BioInfer.d627.s0.p4","sentence":"The influence of these collagens on cell morphology and the distribution pattern of @PROTEIN2$, @PROTEIN1$, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p5","sentence":"The influence of these collagens on cell morphology and the distribution pattern of actin, @PROTEIN1$, talin, and @PROTEIN2$ was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p6","sentence":"The influence of these collagens on cell morphology and the distribution pattern of actin, @PROTEIN1$, @PROTEIN2$, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p7","sentence":"The influence of these collagens on cell morphology and the distribution pattern of @PROTEIN1$, vimentin, talin, and @PROTEIN2$ was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p8","sentence":"The influence of these collagens on cell morphology and the distribution pattern of @PROTEIN1$, vimentin, @PROTEIN2$, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p9","sentence":"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, @PROTEIN2$, and @PROTEIN1$ was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d92.s0.p0","sentence":"Because @PROTEIN1$ is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the @PROTEIN2$ binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p1","sentence":"Because @PROTEIN1$ is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d92.s0.p2","sentence":"Because @PROTEIN1$ is known to interact with alpha-catenin, which binds to @PROTEIN2$, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p3","sentence":"Because @PROTEIN1$ is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of @PROTEIN2$ and the actin binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p4","sentence":"Because @PROTEIN1$ is known to interact with @PROTEIN2$, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.","label":1}
{"pair_id":"BioInfer.d92.s0.p5","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the @PROTEIN1$ binding site of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d92.s0.p6","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to @PROTEIN2$, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the @PROTEIN1$ binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p7","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of @PROTEIN2$ and the @PROTEIN1$ binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p8","sentence":"Because beta-catenin is known to interact with @PROTEIN2$, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the @PROTEIN1$ binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p9","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to @PROTEIN2$, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d92.s0.p10","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of @PROTEIN2$ and the actin binding site of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d92.s0.p11","sentence":"Because beta-catenin is known to interact with @PROTEIN2$, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d92.s0.p12","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to @PROTEIN1$, we generated a fusion molecule consisting of the ectodomain of @PROTEIN2$ and the actin binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p13","sentence":"Because beta-catenin is known to interact with @PROTEIN2$, which binds to @PROTEIN1$, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.","label":1}
{"pair_id":"BioInfer.d92.s0.p14","sentence":"Because beta-catenin is known to interact with @PROTEIN2$, which binds to actin, we generated a fusion molecule consisting of the ectodomain of @PROTEIN1$ and the actin binding site of alpha-catenin.","label":0}
{"pair_id":"AIMed.d144.s1221.p0","sentence":"Moreover, similar @PROTEIN1$ sequences are required for binding @PROTEIN2$ and SV40 large T antigen.","label":1}
{"pair_id":"AIMed.d144.s1221.p1","sentence":"Moreover, similar @PROTEIN1$ sequences are required for binding PP-1 alpha 2 and @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d144.s1221.p2","sentence":"Moreover, similar p110RB sequences are required for binding @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d361.s0.p0","sentence":"Interactions of ADF\/@PROTEIN2$, @PROTEIN1$2\/@PROTEIN1$ complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p1","sentence":"Interactions of @PROTEIN2$\/cofilin, @PROTEIN1$2\/@PROTEIN1$ complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p2","sentence":"Interactions of ADF\/cofilin, @PROTEIN1$2\/@PROTEIN1$ complex, capping protein and profilin in remodeling of branched @PROTEIN2$ filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p3","sentence":"Interactions of ADF\/cofilin, @PROTEIN1$2\/@PROTEIN1$ complex, @PROTEIN2$ and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p4","sentence":"Interactions of ADF\/cofilin, @PROTEIN1$@PROTEIN2$\/@PROTEIN1$ complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p5","sentence":"Interactions of ADF\/cofilin, @PROTEIN1$2\/@PROTEIN1$ complex, capping protein and @PROTEIN2$ in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p6","sentence":"Interactions of @PROTEIN2$\/@PROTEIN1$, Arp2\/A complex, capping protein and profilin in remodeling of branched actin filament networks.","label":0}
{"pair_id":"BioInfer.d361.s0.p7","sentence":"Interactions of ADF\/@PROTEIN1$, Arp2\/A complex, capping protein and profilin in remodeling of branched @PROTEIN2$ filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p8","sentence":"Interactions of ADF\/@PROTEIN1$, Arp2\/A complex, @PROTEIN2$ and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p9","sentence":"Interactions of ADF\/@PROTEIN1$, @PROTEIN2$\/A complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p10","sentence":"Interactions of ADF\/@PROTEIN1$, Arp2\/A complex, capping protein and @PROTEIN2$ in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p11","sentence":"Interactions of @PROTEIN1$\/cofilin, Arp2\/A complex, capping protein and profilin in remodeling of branched @PROTEIN2$ filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p12","sentence":"Interactions of @PROTEIN1$\/cofilin, Arp2\/A complex, @PROTEIN2$ and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p13","sentence":"Interactions of @PROTEIN1$\/cofilin, @PROTEIN2$\/A complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p14","sentence":"Interactions of @PROTEIN1$\/cofilin, Arp2\/A complex, capping protein and @PROTEIN2$ in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p15","sentence":"Interactions of ADF\/cofilin, Arp2\/A complex, @PROTEIN2$ and profilin in remodeling of branched @PROTEIN1$ filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p16","sentence":"Interactions of ADF\/cofilin, @PROTEIN2$\/A complex, capping protein and profilin in remodeling of branched @PROTEIN1$ filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p17","sentence":"Interactions of ADF\/cofilin, Arp2\/A complex, capping protein and @PROTEIN2$ in remodeling of branched @PROTEIN1$ filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p18","sentence":"Interactions of ADF\/cofilin, @PROTEIN2$\/A complex, @PROTEIN1$ and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p19","sentence":"Interactions of ADF\/cofilin, Arp2\/A complex, @PROTEIN1$ and @PROTEIN2$ in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p20","sentence":"Interactions of ADF\/cofilin, @PROTEIN1$\/A complex, capping protein and @PROTEIN2$ in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d7.s3.p0","sentence":"Mechanism of action of Acanthamoeba @PROTEIN1$: demonstration of @PROTEIN2$ species specificity and regulation by micromolar concentrations of MgCl2.","label":0}
{"pair_id":"BioInfer.d375.s0.p0","sentence":"In this model, @PROTEIN1$ can bind both to @PROTEIN2$ monomers with a Kd of about 5 microM and to the barbed end of actin filaments with a Kd of about 50-100 microM.","label":1}
{"pair_id":"BioInfer.d375.s0.p1","sentence":"In this model, @PROTEIN1$ can bind both to actin monomers with a Kd of about 5 microM and to the barbed end of @PROTEIN2$ filaments with a Kd of about 50-100 microM.","label":1}
{"pair_id":"BioInfer.d375.s0.p2","sentence":"In this model, profilin can bind both to @PROTEIN1$ monomers with a Kd of about 5 microM and to the barbed end of @PROTEIN2$ filaments with a Kd of about 50-100 microM.","label":0}
{"pair_id":"AIMed.d130.s1112.p0","sentence":"Cloning of the complete coding region for human @PROTEIN1$ using the two hybrid system and expression of @PROTEIN2$ in E. coli.","label":0}
{"pair_id":"AIMed.d85.s723.p0","sentence":"The main @PROTEIN1$ region implicated in the association with @PROTEIN2$ was found to be the carboxy-terminal SH3 domain.","label":1}
{"pair_id":"BioInfer.d105.s0.p0","sentence":"@PROTEIN2$ is also expressed in endothelial cells and shown to bind vascular endothelial growth factor (@PROTEIN1$), a potent regulator for vasculogenesis and angiogenesis.","label":1}
{"pair_id":"BioInfer.d105.s0.p1","sentence":"Neuropilin-1 is also expressed in endothelial cells and shown to bind @PROTEIN2$ (@PROTEIN1$), a potent regulator for vasculogenesis and angiogenesis.","label":0}
{"pair_id":"BioInfer.d105.s0.p2","sentence":"@PROTEIN1$ is also expressed in endothelial cells and shown to bind @PROTEIN2$ (VEGF), a potent regulator for vasculogenesis and angiogenesis.","label":1}
{"pair_id":"AIMed.d20.s168.p0","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules @PROTEIN1$ and beta, @PROTEIN2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p1","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules @PROTEIN1$ and beta, transforming growth factors (TGF) beta1 and 2, @PROTEIN2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p2","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules @PROTEIN1$ and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (@PROTEIN2$), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p3","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules @PROTEIN1$ and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), @PROTEIN2$ (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p4","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules @PROTEIN1$ and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d20.s168.p5","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, @PROTEIN1$ and 2, @PROTEIN2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p6","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, @PROTEIN1$ and 2, interleukin (IL) 1 and its receptor antagonist (@PROTEIN2$), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p7","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, @PROTEIN1$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), @PROTEIN2$ (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p8","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, @PROTEIN1$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d20.s168.p9","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, @PROTEIN1$ and its receptor antagonist (@PROTEIN2$), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p10","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, @PROTEIN1$ and its receptor antagonist (IL 1ra), @PROTEIN2$ (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p11","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, @PROTEIN1$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d20.s168.p12","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (@PROTEIN1$), @PROTEIN2$ (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p13","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (@PROTEIN1$), CD14 (the receptor for lipopolysaccharide), P and E selectins, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d20.s168.p14","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), @PROTEIN1$ (the receptor for lipopolysaccharide), P and E selectins, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d205.s1776.p0","sentence":"We conclude that stimulation of thymocytes with pervanadate induces the recruitment of @PROTEIN1$ and @PROTEIN2$ to CD5.","label":0}
{"pair_id":"AIMed.d205.s1776.p1","sentence":"We conclude that stimulation of thymocytes with pervanadate induces the recruitment of @PROTEIN1$ and pp120 to @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d205.s1776.p2","sentence":"We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PI 3-kinase and @PROTEIN1$ to @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d216.s1875.p0","sentence":"An arginine side chain (arginine-789) of @PROTEIN1$ is supplied into the active site of @PROTEIN2$ to neutralize developing charges in the transition state.","label":0}
{"pair_id":"BioInfer.d44.s0.p0","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN2$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p1","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant @PROTEIN2$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p2","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN2$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p3","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN2$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p4","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN2$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p5","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN2$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p6","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN2$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p7","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN2$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p8","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN2$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p9","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN2$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p10","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p11","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p12","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p13","sentence":"Although neither activation of @PROTEIN1$ (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p14","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p15","sentence":"Although neither activation of @PROTEIN1$ (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p16","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN2$ mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p17","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN2$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p18","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN2$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p19","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN2$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p20","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN2$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p21","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN2$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p22","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or @PROTEIN2$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p23","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN2$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p24","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN2$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p25","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p26","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p27","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p28","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p29","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p30","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of @PROTEIN1$ (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p31","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN2$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p32","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN2$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p33","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN2$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p34","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN2$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p35","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN2$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p36","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or @PROTEIN2$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p37","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN2$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p38","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN2$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p39","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p40","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p41","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p42","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p43","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p44","sentence":"Although neither activation of BCK1 (MEKK) by the dominant @PROTEIN1$ mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p45","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN2$ pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p46","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/@PROTEIN2$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p47","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/SLG1 and @PROTEIN2$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p48","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN2$, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p49","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN2$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p50","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN2$, RHO2, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p51","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN2$ effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p52","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p53","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p54","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p55","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p56","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p57","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, @PROTEIN1$\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p58","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/@PROTEIN2$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p59","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN2$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p60","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, @PROTEIN2$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p61","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN2$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p62","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as @PROTEIN2$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p63","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN2$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p64","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p65","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p66","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p67","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p68","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p69","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the @PROTEIN1$ pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p70","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN1$\/SLG1 and @PROTEIN2$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p71","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN2$, HCS77\/@PROTEIN1$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p72","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN2$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN1$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p73","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN2$, RHO2, HCS77\/@PROTEIN1$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p74","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN1$\/SLG1 and MID2 also suppressed @PROTEIN2$ effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p75","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN1$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p76","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN1$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p77","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN1$\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p78","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN1$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p79","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN1$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p80","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/@PROTEIN1$\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p81","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN2$, HCS77\/WSC1\/SLG1 and @PROTEIN1$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p82","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN2$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN1$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p83","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN2$, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN1$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p84","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN1$ also suppressed @PROTEIN2$ effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p85","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN1$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p86","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN1$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p87","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN2$ and @PROTEIN1$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p88","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN1$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p89","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN1$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p90","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and @PROTEIN1$ also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p91","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN2$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN1$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p92","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN2$, @PROTEIN1$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p93","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN1$, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN2$ effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p94","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN1$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p95","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN1$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p96","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN1$, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p97","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN1$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p98","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN1$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p99","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, @PROTEIN1$, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p100","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN1$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN2$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p101","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN1$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN2$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p102","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN1$ (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p103","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN1$ (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p104","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN1$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p105","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN1$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p106","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or @PROTEIN1$ (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p107","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or @PROTEIN1$ (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p108","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN1$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN2$ effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p109","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN1$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p110","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN1$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p111","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN1$, RHO2, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p112","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN1$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p113","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN1$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p114","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as @PROTEIN1$, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p115","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN2$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN1$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p116","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN1$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p117","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed @PROTEIN1$ effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p118","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN1$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p119","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN1$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p120","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed @PROTEIN1$ effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p121","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN2$ as a @PROTEIN1$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p122","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN1$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p123","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN1$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p124","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a @PROTEIN1$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p125","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a @PROTEIN1$ dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p126","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN1$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN2$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p127","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked @PROTEIN1$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p128","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked @PROTEIN1$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p129","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked @PROTEIN1$ as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p130","sentence":"Although neither activation of BCK1 (@PROTEIN2$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN1$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p131","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN1$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p132","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/@PROTEIN1$ and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p133","sentence":"Although neither activation of BCK1 (@PROTEIN1$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN2$) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p134","sentence":"Although neither activation of BCK1 (@PROTEIN1$) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p135","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (@PROTEIN1$) or MPK1 (@PROTEIN2$) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"AIMed.d204.s1758.p0","sentence":"Wild-type @PROTEIN1$, as well as the @PROTEIN2$ mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p1","sentence":"Wild-type @PROTEIN1$, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-@PROTEIN2$], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p2","sentence":"Wild-type @PROTEIN1$, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with @PROTEIN2$ or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p3","sentence":"Wild-type MMP-1, as well as the @PROTEIN1$ mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-@PROTEIN2$], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p4","sentence":"Wild-type MMP-1, as well as the @PROTEIN1$ mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with @PROTEIN2$ or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p5","sentence":"Wild-type MMP-1, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-@PROTEIN1$], exhibit enzymatic activity upon cleavage of the prodomain by treatment with @PROTEIN2$ or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d176.s1490.p0","sentence":"Since @PROTEIN1$ and @PROTEIN2$ do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p1","sentence":"Since @PROTEIN1$ and hsp70 do not readily associate on their own, it appears that @PROTEIN2$ is the central organizing component of an hsp90-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p2","sentence":"Since @PROTEIN1$ and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an @PROTEIN2$-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p3","sentence":"Since @PROTEIN1$ and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-@PROTEIN2$-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p4","sentence":"Since @PROTEIN1$ and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-@PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p5","sentence":"Since hsp90 and @PROTEIN1$ do not readily associate on their own, it appears that @PROTEIN2$ is the central organizing component of an hsp90-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p6","sentence":"Since hsp90 and @PROTEIN1$ do not readily associate on their own, it appears that p60 is the central organizing component of an @PROTEIN2$-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p7","sentence":"Since hsp90 and @PROTEIN1$ do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-@PROTEIN2$-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p8","sentence":"Since hsp90 and @PROTEIN1$ do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-@PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p9","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that @PROTEIN1$ is the central organizing component of an @PROTEIN2$-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p10","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that @PROTEIN1$ is the central organizing component of an hsp90-@PROTEIN2$-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p11","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that @PROTEIN1$ is the central organizing component of an hsp90-p60-@PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p12","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an @PROTEIN1$-@PROTEIN2$-hsp70 complex.","label":1}
{"pair_id":"AIMed.d176.s1490.p13","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an @PROTEIN1$-p60-@PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p14","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-@PROTEIN1$-@PROTEIN2$ complex.","label":0}
{"pair_id":"AIMed.d51.s455.p0","sentence":"Here we report the crystal structure of the @PROTEIN1$ ectodomain in a dimeric form that is induced by simultaneous binding to @PROTEIN2$ and a heparin decasaccharide.","label":1}
{"pair_id":"BioInfer.d446.s0.p0","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN2$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p1","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ MEC3, RAD53, CHK1, PDS1, and @PROTEIN2$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p2","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN2$, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p3","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ MEC3, RAD53, @PROTEIN2$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p4","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ MEC3, RAD53, CHK1, @PROTEIN2$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p5","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN2$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p6","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ MEC3, @PROTEIN2$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p7","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN2$, MEC1, @PROTEIN1$ MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p8","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN2$, @PROTEIN1$ MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p9","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, DPB11, MEC1, @PROTEIN1$ MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p10","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ @PROTEIN2$, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p11","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p12","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, @PROTEIN1$ MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p13","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and @PROTEIN2$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p14","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN2$, RAD17, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p15","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, @PROTEIN2$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p16","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, @PROTEIN2$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p17","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN2$, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p18","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, @PROTEIN2$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p19","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN2$, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p20","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN2$, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p21","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p22","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 @PROTEIN2$, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p23","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p24","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, @PROTEIN1$, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p25","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN2$, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p26","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, @PROTEIN2$, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p27","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, @PROTEIN2$, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p28","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN2$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p29","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, @PROTEIN2$, CHK1, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p30","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN2$, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p31","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN2$, DDC2 MEC3, RAD53, CHK1, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p32","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p33","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 @PROTEIN2$, RAD53, CHK1, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p34","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p35","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and @PROTEIN1$ increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p36","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, @PROTEIN2$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p37","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, @PROTEIN2$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p38","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, @PROTEIN2$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p39","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, @PROTEIN2$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p40","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN2$, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p41","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN2$, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p42","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p43","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 @PROTEIN2$, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p44","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p45","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in @PROTEIN1$, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p46","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, @PROTEIN1$, @PROTEIN2$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p47","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, @PROTEIN1$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN2$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p48","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, @PROTEIN2$, @PROTEIN1$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p49","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN2$, MEC1, DDC2 MEC3, RAD53, @PROTEIN1$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p50","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN2$, DDC2 MEC3, RAD53, @PROTEIN1$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p51","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, DPB11, MEC1, DDC2 MEC3, RAD53, @PROTEIN1$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p52","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 @PROTEIN2$, RAD53, @PROTEIN1$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p53","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, @PROTEIN1$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p54","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, @PROTEIN1$, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p55","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, @PROTEIN1$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN2$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p56","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, @PROTEIN2$, CHK1, @PROTEIN1$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p57","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN2$, MEC1, DDC2 MEC3, RAD53, CHK1, @PROTEIN1$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p58","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN2$, DDC2 MEC3, RAD53, CHK1, @PROTEIN1$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p59","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, @PROTEIN1$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p60","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 @PROTEIN2$, RAD53, CHK1, @PROTEIN1$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p61","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, @PROTEIN1$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p62","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, @PROTEIN1$, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p63","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, @PROTEIN2$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN1$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p64","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN2$, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN1$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p65","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN2$, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN1$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p66","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN1$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p67","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 @PROTEIN2$, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN1$, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p68","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN1$, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p69","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, @PROTEIN1$, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p70","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN2$, MEC1, DDC2 MEC3, @PROTEIN1$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p71","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN2$, DDC2 MEC3, @PROTEIN1$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p72","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, DPB11, MEC1, DDC2 MEC3, @PROTEIN1$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p73","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 @PROTEIN2$, @PROTEIN1$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p74","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, @PROTEIN1$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p75","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, @PROTEIN1$, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p76","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN1$, @PROTEIN2$, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p77","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, @PROTEIN1$, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p78","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN1$, MEC1, DDC2 @PROTEIN2$, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p79","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN1$, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p80","sentence":"Mutations in Saccharomyces cerevisiae RFC5, @PROTEIN1$, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p81","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN2$, DPB11, @PROTEIN1$, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p82","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN1$, DDC2 @PROTEIN2$, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p83","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN1$, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p84","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, @PROTEIN1$, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p85","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN1$, DPB11, MEC1, DDC2 @PROTEIN2$, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p86","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN1$, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p87","sentence":"Mutations in Saccharomyces cerevisiae @PROTEIN1$, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p88","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 @PROTEIN1$, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN2$, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p89","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 @PROTEIN1$, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p90","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, @PROTEIN1$, and @PROTEIN2$ had little effect.","label":0}
{"pair_id":"AIMed.d174.s1471.p0","sentence":"The increased binding affinity of @PROTEIN1$ appears to be due to its ability to cross-link two @PROTEIN2$ molecules on the biosensor surface.","label":1}
{"pair_id":"BioInfer.d68.s1.p0","sentence":"@PROTEIN1$-tagged ORC1 associated with chromatin throughout mitosis in living cells and co-localized with @PROTEIN2$ in metaphase spreads.","label":0}
{"pair_id":"BioInfer.d68.s1.p1","sentence":"@PROTEIN1$-tagged @PROTEIN2$ associated with chromatin throughout mitosis in living cells and co-localized with ORC4 in metaphase spreads.","label":1}
{"pair_id":"BioInfer.d68.s1.p2","sentence":"Green fluorescent protein-tagged @PROTEIN2$ associated with chromatin throughout mitosis in living cells and co-localized with @PROTEIN1$ in metaphase spreads.","label":1}
{"pair_id":"BioInfer.d321.s1.p0","sentence":"In this study, we immunohistochemically investigated the expression of @PROTEIN1$ as well as E-cadherin and @PROTEIN2$ in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.","label":0}
{"pair_id":"BioInfer.d321.s1.p1","sentence":"In this study, we immunohistochemically investigated the expression of @PROTEIN1$ as well as @PROTEIN2$ and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.","label":0}
{"pair_id":"BioInfer.d321.s1.p2","sentence":"In this study, we immunohistochemically investigated the expression of beta-catenin as well as @PROTEIN2$ and @PROTEIN1$ in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.","label":0}
{"pair_id":"AIMed.d131.s1122.p0","sentence":"Mouse @PROTEIN1$ does not bind to @PROTEIN2$, and hIL-10R-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.","label":0}
{"pair_id":"AIMed.d131.s1122.p1","sentence":"Mouse @PROTEIN1$ does not bind to hIL-10R, and @PROTEIN2$-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.","label":0}
{"pair_id":"AIMed.d131.s1122.p2","sentence":"Mouse @PROTEIN1$ does not bind to hIL-10R, and hIL-10R-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1122.p3","sentence":"Mouse IL-10 does not bind to @PROTEIN1$, and @PROTEIN2$-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.","label":0}
{"pair_id":"AIMed.d131.s1122.p4","sentence":"Mouse IL-10 does not bind to @PROTEIN1$, and hIL-10R-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d131.s1122.p5","sentence":"Mouse IL-10 does not bind to hIL-10R, and @PROTEIN1$-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d102.s859.p0","sentence":"The @PROTEIN1$-susceptibility gene product binds directly to the human @PROTEIN2$-associated factor TAFII250.","label":0}
{"pair_id":"AIMed.d102.s859.p1","sentence":"The @PROTEIN1$-susceptibility gene product binds directly to the human @PROTEIN2$ TAFII250.","label":0}
{"pair_id":"AIMed.d102.s859.p2","sentence":"The @PROTEIN1$-susceptibility gene product binds directly to the human TATA-binding protein-associated factor @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d102.s859.p3","sentence":"The retinoblastoma-susceptibility gene product binds directly to the human @PROTEIN1$@PROTEIN2$ TAFII250.","label":0}
{"pair_id":"AIMed.d102.s859.p4","sentence":"The retinoblastoma-susceptibility gene product binds directly to the human @PROTEIN1$-associated factor @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d102.s859.p5","sentence":"The retinoblastoma-susceptibility gene product binds directly to the human @PROTEIN1$ @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d166.s1394.p0","sentence":"Residues in human @PROTEIN1$ (@PROTEIN2$) crucial for binding to both the human LIF receptor (R) and gp130 were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p1","sentence":"Residues in human @PROTEIN1$ (hLIF) crucial for binding to both the human @PROTEIN2$ (R) and gp130 were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":1}
{"pair_id":"AIMed.d166.s1394.p2","sentence":"Residues in human @PROTEIN1$ (hLIF) crucial for binding to both the human LIF receptor (R) and @PROTEIN2$ were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":1}
{"pair_id":"AIMed.d166.s1394.p3","sentence":"Residues in human @PROTEIN1$ (hLIF) crucial for binding to both the human LIF receptor (R) and gp130 were identified by analysis of alanine scanning mutants of @PROTEIN2$ in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p4","sentence":"Residues in human leukemia inhibitory factor (@PROTEIN1$) crucial for binding to both the human @PROTEIN2$ (R) and gp130 were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":1}
{"pair_id":"AIMed.d166.s1394.p5","sentence":"Residues in human leukemia inhibitory factor (@PROTEIN1$) crucial for binding to both the human LIF receptor (R) and @PROTEIN2$ were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":1}
{"pair_id":"AIMed.d166.s1394.p6","sentence":"Residues in human leukemia inhibitory factor (@PROTEIN1$) crucial for binding to both the human LIF receptor (R) and gp130 were identified by analysis of alanine scanning mutants of @PROTEIN2$ in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p7","sentence":"Residues in human leukemia inhibitory factor (hLIF) crucial for binding to both the human @PROTEIN1$ (R) and @PROTEIN2$ were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p8","sentence":"Residues in human leukemia inhibitory factor (hLIF) crucial for binding to both the human @PROTEIN1$ (R) and gp130 were identified by analysis of alanine scanning mutants of @PROTEIN2$ in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p9","sentence":"Residues in human leukemia inhibitory factor (hLIF) crucial for binding to both the human LIF receptor (R) and @PROTEIN1$ were identified by analysis of alanine scanning mutants of @PROTEIN2$ in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"BioInfer.d397.s0.p0","sentence":"It therefore appears that @PROTEIN1$ and @PROTEIN2$ multigene families are both expressed in a species specific fashion but are independently regulated within a species.","label":1}
{"pair_id":"AIMed.d183.s1553.p0","sentence":"@PROTEIN1$, a member of the Janus kinase superfamily was found to interact functionally with @PROTEIN2$, a central component of the ras\/mitogen-activated protein kinase signal transduction pathway.","label":1}
{"pair_id":"AIMed.d183.s1553.p1","sentence":"@PROTEIN1$, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the @PROTEIN2$\/mitogen-activated protein kinase signal transduction pathway.","label":0}
{"pair_id":"AIMed.d183.s1553.p2","sentence":"@PROTEIN1$, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the ras\/@PROTEIN2$ signal transduction pathway.","label":0}
{"pair_id":"AIMed.d183.s1553.p3","sentence":"JAK2, a member of the Janus kinase superfamily was found to interact functionally with @PROTEIN1$, a central component of the @PROTEIN2$\/mitogen-activated protein kinase signal transduction pathway.","label":0}
{"pair_id":"AIMed.d183.s1553.p4","sentence":"JAK2, a member of the Janus kinase superfamily was found to interact functionally with @PROTEIN1$, a central component of the ras\/@PROTEIN2$ signal transduction pathway.","label":0}
{"pair_id":"AIMed.d183.s1553.p5","sentence":"JAK2, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the @PROTEIN1$\/@PROTEIN2$ signal transduction pathway.","label":0}
{"pair_id":"BioInfer.d568.s0.p0","sentence":"The activation of the @PROTEIN1$-@PROTEIN2$ protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p1","sentence":"The activation of the @PROTEIN1$-ER protein leads to an accumulation of high levels of @PROTEIN2$ protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p2","sentence":"The activation of the @PROTEIN1$-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 @PROTEIN2$ under all culture conditions tested.","label":0}
{"pair_id":"BioInfer.d568.s0.p3","sentence":"The activation of the @PROTEIN1$-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the @PROTEIN2$ cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p4","sentence":"The activation of the c-Raf-1-BxB-@PROTEIN1$ protein leads to an accumulation of high levels of @PROTEIN2$ protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p5","sentence":"The activation of the c-Raf-1-BxB-@PROTEIN1$ protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 @PROTEIN2$ under all culture conditions tested.","label":0}
{"pair_id":"BioInfer.d568.s0.p6","sentence":"The activation of the c-Raf-1-BxB-@PROTEIN1$ protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the @PROTEIN2$ cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p7","sentence":"The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of @PROTEIN1$ protein and a repression of the p27Kip1 @PROTEIN2$ under all culture conditions tested.","label":0}
{"pair_id":"BioInfer.d568.s0.p8","sentence":"The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of @PROTEIN1$ protein and a repression of the @PROTEIN2$ cyclin-dependent kinase inhibitor under all culture conditions tested.","label":0}
{"pair_id":"BioInfer.d568.s0.p9","sentence":"The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the @PROTEIN2$ @PROTEIN1$ under all culture conditions tested.","label":1}
{"pair_id":"AIMed.d26.s218.p0","sentence":"In contrast, cancer patients exhibited significantly decreased levels of @PROTEIN1$ expression ( P<0.005), despite having equally high levels of @PROTEIN2$ expression in comparison with healthy controls.","label":0}
{"pair_id":"BioInfer.d100.s0.p0","sentence":"Biochemical complementation experiments also indicate that the @PROTEIN2$ and @PROTEIN1$ proteins interact.","label":1}
{"pair_id":"AIMed.d199.s1698.p0","sentence":"Activation of @PROTEIN1$ upon ligand binding resulted in activation of @PROTEIN2$ pathway.","label":0}
{"pair_id":"AIMed.d76.s645.p0","sentence":"No binding between @PROTEIN1$(T) and @PROTEIN2$ was detected in T cells.","label":0}
{"pair_id":"AIMed.d151.s1286.p0","sentence":"We now report the isolation and expression of cDNAs encoding @PROTEIN1$ gamma and @PROTEIN2$ delta, as well as functional studies with cognate antibodies that recognize the native PTF complex in HeLa extracts.","label":0}
{"pair_id":"AIMed.d151.s1286.p1","sentence":"We now report the isolation and expression of cDNAs encoding @PROTEIN1$ gamma and PTF delta, as well as functional studies with cognate antibodies that recognize the native @PROTEIN2$ complex in HeLa extracts.","label":0}
{"pair_id":"AIMed.d151.s1286.p2","sentence":"We now report the isolation and expression of cDNAs encoding PTF gamma and @PROTEIN1$ delta, as well as functional studies with cognate antibodies that recognize the native @PROTEIN2$ complex in HeLa extracts.","label":0}
{"pair_id":"AIMed.d187.s1590.p0","sentence":"In physiological buffers and CSF, @PROTEIN1$ exclusively decreased the level of @PROTEIN2$ pentamers.","label":0}
{"pair_id":"BioInfer.d430.s1.p0","sentence":"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of @PROTEIN1$, alpha-catenin and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d430.s1.p1","sentence":"One complex is composed of E-cadherin, @PROTEIN2$ and beta-@PROTEIN2$, the other of @PROTEIN1$, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p2","sentence":"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of @PROTEIN1$, @PROTEIN2$ and plakoglobin.","label":1}
{"pair_id":"BioInfer.d430.s1.p3","sentence":"One complex is composed of @PROTEIN2$, alpha- and beta-catenin, the other of @PROTEIN1$, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p4","sentence":"One complex is composed of E-cadherin, alpha- and @PROTEIN2$, the other of @PROTEIN1$, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p5","sentence":"One complex is composed of E-cadherin, @PROTEIN2$ and beta-@PROTEIN2$, the other of E-cadherin, alpha-catenin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d430.s1.p6","sentence":"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, @PROTEIN2$ and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d430.s1.p7","sentence":"One complex is composed of @PROTEIN2$, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d430.s1.p8","sentence":"One complex is composed of E-cadherin, alpha- and @PROTEIN2$, the other of E-cadherin, alpha-catenin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d430.s1.p9","sentence":"One complex is composed of E-cadherin, @PROTEIN1$ and beta-@PROTEIN1$, the other of E-cadherin, @PROTEIN2$ and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p10","sentence":"One complex is composed of @PROTEIN2$, @PROTEIN1$ and beta-@PROTEIN1$, the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d430.s1.p11","sentence":"One complex is composed of E-cadherin, @PROTEIN1$ and @PROTEIN2$@PROTEIN1$, the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d430.s1.p12","sentence":"One complex is composed of @PROTEIN2$, alpha- and beta-catenin, the other of E-cadherin, @PROTEIN1$ and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p13","sentence":"One complex is composed of E-cadherin, alpha- and @PROTEIN2$, the other of E-cadherin, @PROTEIN1$ and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p14","sentence":"One complex is composed of @PROTEIN1$, alpha- and @PROTEIN2$, the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d452.s0.p0","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the @PROTEIN1$, @PROTEIN2$, and gelsolin.","label":1}
{"pair_id":"BioInfer.d452.s0.p1","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of @PROTEIN2$ assembly through its association with the @PROTEIN1$, profilin, and gelsolin.","label":0}
{"pair_id":"BioInfer.d452.s0.p2","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the @PROTEIN1$, profilin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d452.s0.p3","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of @PROTEIN2$ assembly through its association with the actin-binding proteins, @PROTEIN1$, and gelsolin.","label":1}
{"pair_id":"BioInfer.d452.s0.p4","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d452.s0.p5","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of @PROTEIN1$ assembly through its association with the actin-binding proteins, profilin, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d515.s0.p0","sentence":"Regulation of @PROTEIN1$ and @PROTEIN2$ isogenes during cardiac growth and hypertrophy.","label":0}
{"pair_id":"BioInfer.d65.s1.p0","sentence":"The cellular tumor antigen @PROTEIN1$ is bound to the simian virus 40 (SV40) @PROTEIN2$ in SV40-infected and -transformed cells.","label":1}
{"pair_id":"AIMed.d33.s278.p0","sentence":"A van't Hoff plot of the change in Kd was linear between 10 and 37 degrees C and yielded values of DeltaH degrees = -12.9 kcal\/mol and DeltaS degrees = -15.9 cal mol-1 deg-1, suggesting that electrostatic forces play a prominent role in the interaction of @PROTEIN1$ with @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d828.s0.p0","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue @PROTEIN2$delta O6 MeG DNA repair @PROTEIN1$-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p1","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, @PROTEIN2$, and PMS1, did not rescue mgt1delta O6 MeG DNA repair @PROTEIN1$-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p2","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and @PROTEIN2$, did not rescue mgt1delta O6 MeG DNA repair @PROTEIN1$-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p3","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, @PROTEIN2$, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair @PROTEIN1$-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p4","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, @PROTEIN2$, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair @PROTEIN1$-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p5","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including @PROTEIN2$, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair @PROTEIN1$-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p6","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, @PROTEIN2$, and PMS1, did not rescue @PROTEIN1$delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p7","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and @PROTEIN2$, did not rescue @PROTEIN1$delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p8","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, @PROTEIN2$, MSH3, MSH6, and PMS1, did not rescue @PROTEIN1$delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p9","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, @PROTEIN2$, MSH6, and PMS1, did not rescue @PROTEIN1$delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p10","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including @PROTEIN2$, MSH2, MSH3, MSH6, and PMS1, did not rescue @PROTEIN1$delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p11","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, @PROTEIN1$, and @PROTEIN2$, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p12","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, @PROTEIN2$, MSH3, @PROTEIN1$, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p13","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, @PROTEIN2$, @PROTEIN1$, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p14","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including @PROTEIN2$, MSH2, MSH3, @PROTEIN1$, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p15","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, @PROTEIN2$, MSH3, MSH6, and @PROTEIN1$, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p16","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, @PROTEIN2$, MSH6, and @PROTEIN1$, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p17","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including @PROTEIN2$, MSH2, MSH3, MSH6, and @PROTEIN1$, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p18","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, @PROTEIN1$, @PROTEIN2$, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p19","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including @PROTEIN2$, @PROTEIN1$, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p20","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including @PROTEIN2$, MSH2, @PROTEIN1$, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"AIMed.d113.s960.p0","sentence":"The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to @PROTEIN1$-independent pathways may instead reflect a need for the combination of @PROTEIN2$ and BAG-1.","label":0}
{"pair_id":"AIMed.d113.s960.p1","sentence":"The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to @PROTEIN1$-independent pathways may instead reflect a need for the combination of Bcl-2 and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d113.s960.p2","sentence":"The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to Bcl-2-independent pathways may instead reflect a need for the combination of @PROTEIN1$ and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d178.s0.p0","sentence":"DNA sequence analysis of the @PROTEIN2$ gene reveals that it encodes @PROTEIN1$, an actin-monomer-binding protein.","label":1}
{"pair_id":"BioInfer.d178.s0.p1","sentence":"DNA sequence analysis of the cdc3+ gene reveals that it encodes @PROTEIN1$, an @PROTEIN2$-monomer-binding protein.","label":1}
{"pair_id":"BioInfer.d178.s0.p2","sentence":"DNA sequence analysis of the @PROTEIN1$ gene reveals that it encodes profilin, an @PROTEIN2$-monomer-binding protein.","label":0}
{"pair_id":"AIMed.d104.s879.p0","sentence":"The first cDNA from the @PROTEIN1$ family to be cloned was designated @PROTEIN2$, and multiple E2F family members have now been identified.","label":0}
{"pair_id":"AIMed.d104.s879.p1","sentence":"The first cDNA from the @PROTEIN1$ family to be cloned was designated E2F-1, and multiple @PROTEIN2$ family members have now been identified.","label":0}
{"pair_id":"AIMed.d104.s879.p2","sentence":"The first cDNA from the E2F family to be cloned was designated @PROTEIN1$, and multiple @PROTEIN2$ family members have now been identified.","label":0}
{"pair_id":"AIMed.d207.s1787.p0","sentence":"@PROTEIN1$ prevents @PROTEIN2$\/cdk2 containing E2F complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"AIMed.d207.s1787.p1","sentence":"@PROTEIN1$ prevents cyclinA\/@PROTEIN2$ containing E2F complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"AIMed.d207.s1787.p2","sentence":"@PROTEIN1$ prevents cyclinA\/cdk2 containing @PROTEIN2$ complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"AIMed.d207.s1787.p3","sentence":"MyoD prevents @PROTEIN1$\/@PROTEIN2$ containing E2F complexes formation in terminally differentiated myocytes.","label":1}
{"pair_id":"AIMed.d207.s1787.p4","sentence":"MyoD prevents @PROTEIN1$\/cdk2 containing @PROTEIN2$ complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"AIMed.d207.s1787.p5","sentence":"MyoD prevents cyclinA\/@PROTEIN1$ containing @PROTEIN2$ complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"BioInfer.d406.s0.p0","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes @PROTEIN2$, MSH2, MSH3, and @PROTEIN1$ (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p1","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, @PROTEIN2$, and @PROTEIN1$ (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p2","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, @PROTEIN2$, MSH3, and @PROTEIN1$ (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p3","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and @PROTEIN1$ (@PROTEIN2$) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p4","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes @PROTEIN1$, MSH2, @PROTEIN2$, and MSH6 (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p5","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes @PROTEIN1$, @PROTEIN2$, MSH3, and MSH6 (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p6","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes @PROTEIN1$, MSH2, MSH3, and MSH6 (@PROTEIN2$) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p7","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, @PROTEIN2$, @PROTEIN1$, and MSH6 (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p8","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, @PROTEIN1$, and MSH6 (@PROTEIN2$) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p9","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, @PROTEIN1$, MSH3, and MSH6 (@PROTEIN2$) was investigated.","label":0}
{"pair_id":"AIMed.d17.s147.p0","sentence":"In addition, a possible role for @PROTEIN1$, the product of @PROTEIN2$, in atherosclerotic lesion development is put into perspective.","label":0}
{"pair_id":"BioInfer.d712.s0.p0","sentence":"These results suggest that @PROTEIN1$ may be involved in the pathogenesis of glomerulonephritis by reorganizing @PROTEIN2$ cytoskeleton.","label":1}
{"pair_id":"BioInfer.d379.s1.p0","sentence":"Redundancy of Saccharomyces cerevisiae @PROTEIN2$ and MSH6 in @PROTEIN1$-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d379.s1.p1","sentence":"Redundancy of Saccharomyces cerevisiae MSH3 and @PROTEIN2$ in @PROTEIN1$-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d379.s1.p2","sentence":"Redundancy of Saccharomyces cerevisiae @PROTEIN1$ and @PROTEIN2$ in MSH2-dependent mismatch repair.","label":0}
{"pair_id":"AIMed.d2.s17.p0","sentence":"The molar ratio of serum @PROTEIN1$ (@PROTEIN2$) to transthyretin (TTR) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p1","sentence":"The molar ratio of serum @PROTEIN1$ (RBP) to @PROTEIN2$ (TTR) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p2","sentence":"The molar ratio of serum @PROTEIN1$ (RBP) to transthyretin (@PROTEIN2$) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p3","sentence":"The molar ratio of serum retinol-binding protein (@PROTEIN1$) to @PROTEIN2$ (TTR) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p4","sentence":"The molar ratio of serum retinol-binding protein (@PROTEIN1$) to transthyretin (@PROTEIN2$) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p5","sentence":"The molar ratio of serum retinol-binding protein (RBP) to @PROTEIN1$ (@PROTEIN2$) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"BioInfer.d372.s0.p0","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or @PROTEIN1$ promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d372.s0.p1","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the @PROTEIN2$), to the CYBB or @PROTEIN1$ promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p2","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or @PROTEIN1$ promoter is the molecular mechanism of transcriptional activation by @PROTEIN2$, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p3","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or @PROTEIN1$ promoter is the molecular mechanism of transcriptional activation by PU.1, @PROTEIN2$, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p4","sentence":"In these investigations, we determine that recruitment of a coactivator protein, @PROTEIN2$ (the CREBbinding protein), to the CYBB or @PROTEIN1$ promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p5","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the @PROTEIN2$ or @PROTEIN1$ promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p6","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the @PROTEIN2$), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d372.s0.p7","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by @PROTEIN2$, IRF1, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d372.s0.p8","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, @PROTEIN2$, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d372.s0.p9","sentence":"In these investigations, we determine that recruitment of a coactivator protein, @PROTEIN2$ (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d372.s0.p10","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the @PROTEIN2$ or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d372.s0.p11","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the @PROTEIN1$), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by @PROTEIN2$, IRF1, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p12","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the @PROTEIN1$), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, @PROTEIN2$, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p13","sentence":"In these investigations, we determine that recruitment of a coactivator protein, @PROTEIN2$ (the @PROTEIN1$), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p14","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the @PROTEIN1$), to the @PROTEIN2$ or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p15","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by @PROTEIN1$, @PROTEIN2$, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p16","sentence":"In these investigations, we determine that recruitment of a coactivator protein, @PROTEIN2$ (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by @PROTEIN1$, IRF1, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p17","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the @PROTEIN2$ or NCF2 promoter is the molecular mechanism of transcriptional activation by @PROTEIN1$, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p18","sentence":"In these investigations, we determine that recruitment of a coactivator protein, @PROTEIN2$ (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, @PROTEIN1$, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p19","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the @PROTEIN2$ or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, @PROTEIN1$, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p20","sentence":"In these investigations, we determine that recruitment of a coactivator protein, @PROTEIN1$ (the CREBbinding protein), to the @PROTEIN2$ or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d420.s0.p0","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, @PROTEIN1$ and plakoglobin and a polyclonal antibody against @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d420.s0.p1","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against @PROTEIN2$, @PROTEIN1$ and plakoglobin and a polyclonal antibody against alpha-catenin.","label":0}
{"pair_id":"BioInfer.d420.s0.p2","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, @PROTEIN1$ and @PROTEIN2$ and a polyclonal antibody against alpha-catenin.","label":0}
{"pair_id":"BioInfer.d420.s0.p3","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against @PROTEIN2$, beta-catenin and plakoglobin and a polyclonal antibody against @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d420.s0.p4","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and @PROTEIN2$ and a polyclonal antibody against @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d420.s0.p5","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against @PROTEIN1$, beta-catenin and @PROTEIN2$ and a polyclonal antibody against alpha-catenin.","label":0}
{"pair_id":"AIMed.d126.s1072.p0","sentence":"The rates of commitment to renaturation of @PROTEIN1$ and @PROTEIN2$ in the presence of the groE chaperonins.","label":0}
{"pair_id":"AIMed.d190.s1611.p0","sentence":"Hemopoietic cell proliferation is mediated by non-tyrosine and tyrosine kinases that signal via uncommon and common sets of downstream effector molecules including the @PROTEIN1$\/@PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d427.s0.p0","sentence":"@PROTEIN1$ is fused in-frame to a different exon of @PROTEIN2$ in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p1","sentence":"@PROTEIN1$ is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d427.s0.p2","sentence":"@PROTEIN1$ is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the @PROTEIN2$ binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p3","sentence":"@PROTEIN1$ is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of @PROTEIN2$ fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p4","sentence":"@PROTEIN1$ is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, @PROTEIN2$ homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p5","sentence":"MLL is fused in-frame to a different exon of @PROTEIN1$ in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d427.s0.p6","sentence":"MLL is fused in-frame to a different exon of @PROTEIN1$ in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the @PROTEIN2$ binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p7","sentence":"MLL is fused in-frame to a different exon of @PROTEIN1$ in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of @PROTEIN2$ fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p8","sentence":"MLL is fused in-frame to a different exon of @PROTEIN1$ in two patients producing chimeric proteins containing the AT-hooks, @PROTEIN2$ homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p9","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the @PROTEIN2$ binding domain or to the bromodomain of @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d427.s0.p10","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of @PROTEIN2$ fused to the CREB binding domain or to the bromodomain of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d427.s0.p11","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, @PROTEIN2$ homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d427.s0.p12","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of @PROTEIN2$ fused to the @PROTEIN1$ binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p13","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, @PROTEIN2$ homology domain, and transcriptional repression domain of MLL fused to the @PROTEIN1$ binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p14","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, @PROTEIN2$ homology domain, and transcriptional repression domain of @PROTEIN1$ fused to the CREB binding domain or to the bromodomain of CBP.","label":1}
{"pair_id":"BioInfer.d413.s0.p0","sentence":"MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with @PROTEIN1$'s binding to @PROTEIN2$ was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p1","sentence":"MATERIALS AND METHODS: A mutation in the @PROTEIN2$ (Myh) predicted to interfere strongly with @PROTEIN1$'s binding to actin was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p2","sentence":"MATERIALS AND METHODS: A mutation in the myosin heavy chain (@PROTEIN2$) predicted to interfere strongly with @PROTEIN1$'s binding to actin was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p3","sentence":"MATERIALS AND METHODS: A mutation in the @PROTEIN2$ (Myh) predicted to interfere strongly with myosin's binding to @PROTEIN1$ was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p4","sentence":"MATERIALS AND METHODS: A mutation in the myosin heavy chain (@PROTEIN2$) predicted to interfere strongly with myosin's binding to @PROTEIN1$ was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p5","sentence":"MATERIALS AND METHODS: A mutation in the @PROTEIN1$ (@PROTEIN2$) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.","label":0}
{"pair_id":"AIMed.d185.s1572.p0","sentence":"In all cells tested, @PROTEIN1$ activated @PROTEIN2$ and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.","label":1}
{"pair_id":"AIMed.d185.s1572.p1","sentence":"In all cells tested, @PROTEIN1$ activated Stat1 and @PROTEIN2$ and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.","label":1}
{"pair_id":"AIMed.d185.s1572.p2","sentence":"In all cells tested, IL-10 activated @PROTEIN1$ and @PROTEIN2$ and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.","label":0}
{"pair_id":"BioInfer.d395.s1.p0","sentence":"Native @PROTEIN2$, purified from extracts of lung epithelial cells by affinity binding to a poly-L-proline matrix, stimulated the @PROTEIN1$-saturated RSV transcription by 2.5- to 3-fold.","label":1}
{"pair_id":"AIMed.d150.s1274.p0","sentence":"The @PROTEIN1$ gene product (@PROTEIN2$) is a nuclear phosphoprotein that regulates cell cycle progression.","label":0}
{"pair_id":"AIMed.d219.s1903.p0","sentence":"Recent studies indicate that the structural integrity of the @PROTEIN1$ is also critical for @PROTEIN2$ interaction with 14-3-3 proteins.","label":0}
{"pair_id":"AIMed.d197.s1676.p0","sentence":"The interaction between @PROTEIN1$ (@PROTEIN2$) and IL-6 receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p1","sentence":"The interaction between @PROTEIN1$ (IL-6) and @PROTEIN2$ receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p2","sentence":"The interaction between @PROTEIN1$ (IL-6) and @PROTEIN2$ (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":1}
{"pair_id":"AIMed.d197.s1676.p3","sentence":"The interaction between @PROTEIN1$ (IL-6) and IL-6 receptor (@PROTEIN2$) is the initial and most specific step in the IL-6 signaling pathway.","label":1}
{"pair_id":"AIMed.d197.s1676.p4","sentence":"The interaction between @PROTEIN1$ (IL-6) and IL-6 receptor (IL-6R) is the initial and most specific step in the @PROTEIN2$ signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p5","sentence":"The interaction between interleukin-6 (@PROTEIN1$) and @PROTEIN2$ receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p6","sentence":"The interaction between interleukin-6 (@PROTEIN1$) and @PROTEIN2$ (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":1}
{"pair_id":"AIMed.d197.s1676.p7","sentence":"The interaction between interleukin-6 (@PROTEIN1$) and IL-6 receptor (@PROTEIN2$) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p8","sentence":"The interaction between interleukin-6 (@PROTEIN1$) and IL-6 receptor (IL-6R) is the initial and most specific step in the @PROTEIN2$ signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p9","sentence":"The interaction between interleukin-6 (IL-6) and @PROTEIN1$@PROTEIN2$ (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p10","sentence":"The interaction between interleukin-6 (IL-6) and @PROTEIN1$ receptor (@PROTEIN2$) is the initial and most specific step in the IL-6 signaling pathway.","label":1}
{"pair_id":"AIMed.d197.s1676.p11","sentence":"The interaction between interleukin-6 (IL-6) and @PROTEIN1$ receptor (IL-6R) is the initial and most specific step in the @PROTEIN2$ signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p12","sentence":"The interaction between interleukin-6 (IL-6) and @PROTEIN1$ (@PROTEIN2$) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p13","sentence":"The interaction between interleukin-6 (IL-6) and @PROTEIN1$ (IL-6R) is the initial and most specific step in the @PROTEIN2$ signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p14","sentence":"The interaction between interleukin-6 (IL-6) and IL-6 receptor (@PROTEIN1$) is the initial and most specific step in the @PROTEIN2$ signaling pathway.","label":0}
{"pair_id":"AIMed.d76.s641.p0","sentence":"In this study, we demonstrate that @PROTEIN1$ is coupled to the protein-tyrosine kinase @PROTEIN2$ and can act as a substrate for p56lck.","label":1}
{"pair_id":"AIMed.d76.s641.p1","sentence":"In this study, we demonstrate that @PROTEIN1$ is coupled to the protein-tyrosine kinase p56lck and can act as a substrate for @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d76.s641.p2","sentence":"In this study, we demonstrate that CD5 is coupled to the protein-tyrosine kinase @PROTEIN1$ and can act as a substrate for @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d292.s0.p0","sentence":"Immunohistochemical investigation of @PROTEIN1$-anchoring proteins vinculin, talin and @PROTEIN2$ in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":1}
{"pair_id":"BioInfer.d292.s0.p1","sentence":"Immunohistochemical investigation of @PROTEIN1$-anchoring proteins vinculin, @PROTEIN2$ and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":1}
{"pair_id":"BioInfer.d292.s0.p2","sentence":"Immunohistochemical investigation of @PROTEIN1$-anchoring proteins @PROTEIN2$, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":1}
{"pair_id":"BioInfer.d292.s0.p3","sentence":"Immunohistochemical investigation of actin-anchoring proteins vinculin, @PROTEIN2$ and @PROTEIN1$ in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":0}
{"pair_id":"BioInfer.d292.s0.p4","sentence":"Immunohistochemical investigation of actin-anchoring proteins @PROTEIN2$, talin and @PROTEIN1$ in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":0}
{"pair_id":"BioInfer.d292.s0.p5","sentence":"Immunohistochemical investigation of actin-anchoring proteins @PROTEIN2$, @PROTEIN1$ and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":0}
{"pair_id":"AIMed.d102.s864.p0","sentence":"The stimulation of @PROTEIN1$-mediated transcription by @PROTEIN2$ in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human TAFII250.","label":0}
{"pair_id":"AIMed.d102.s864.p1","sentence":"The stimulation of @PROTEIN1$-mediated transcription by RB in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d102.s864.p2","sentence":"The stimulation of Sp1-mediated transcription by @PROTEIN1$ in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d128.s1099.p0","sentence":"Comparisons with the @PROTEIN1$-@PROTEIN2$ complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.","label":1}
{"pair_id":"AIMed.d128.s1099.p1","sentence":"Comparisons with the @PROTEIN1$-hGHR complex reveal how @PROTEIN2$ can bind to the two distinctly different receptor binding surfaces.","label":0}
{"pair_id":"AIMed.d128.s1099.p2","sentence":"Comparisons with the hGH-@PROTEIN1$ complex reveal how @PROTEIN2$ can bind to the two distinctly different receptor binding surfaces.","label":0}
{"pair_id":"BioInfer.d713.s1.p0","sentence":"We report here that LIMK1 and @PROTEIN1$ phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed @PROTEIN2$ mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p1","sentence":"We report here that @PROTEIN2$ and @PROTEIN1$ phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p2","sentence":"We report here that LIMK1 and @PROTEIN1$ phosphorylate both cofilin and actin-depolymerizing factor (@PROTEIN2$) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p3","sentence":"We report here that LIMK1 and @PROTEIN1$ phosphorylate both @PROTEIN2$ and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p4","sentence":"We report here that LIMK1 and @PROTEIN1$ phosphorylate both cofilin and @PROTEIN2$ (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p5","sentence":"We report here that @PROTEIN2$ and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed @PROTEIN1$ mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p6","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (@PROTEIN2$) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed @PROTEIN1$ mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p7","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both @PROTEIN2$ and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed @PROTEIN1$ mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p8","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both cofilin and @PROTEIN2$ (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed @PROTEIN1$ mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p9","sentence":"We report here that @PROTEIN1$ and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (@PROTEIN2$) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p10","sentence":"We report here that @PROTEIN1$ and LIMK2 phosphorylate both @PROTEIN2$ and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p11","sentence":"We report here that @PROTEIN1$ and LIMK2 phosphorylate both cofilin and @PROTEIN2$ (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p12","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both @PROTEIN2$ and actin-depolymerizing factor (@PROTEIN1$) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p13","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both cofilin and @PROTEIN2$ (@PROTEIN1$) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p14","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both @PROTEIN1$ and @PROTEIN2$ (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":0}
{"pair_id":"AIMed.d136.s1154.p0","sentence":"Monoclonal antibodies to the beta chain of the @PROTEIN1$ receptor inhibited the biological activity of @PROTEIN2$, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p1","sentence":"Monoclonal antibodies to the beta chain of the @PROTEIN1$ receptor inhibited the biological activity of IL-15, and @PROTEIN2$ competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p2","sentence":"Monoclonal antibodies to the beta chain of the @PROTEIN1$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with @PROTEIN2$, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p3","sentence":"Monoclonal antibodies to the beta chain of the @PROTEIN1$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that @PROTEIN2$ uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p4","sentence":"Monoclonal antibodies to the beta chain of the @PROTEIN1$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p5","sentence":"Monoclonal antibodies to the beta chain of the @PROTEIN1$ receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d136.s1154.p6","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of @PROTEIN1$, and @PROTEIN2$ competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p7","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of @PROTEIN1$, and IL-15 competed for binding with @PROTEIN2$, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p8","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of @PROTEIN1$, and IL-15 competed for binding with IL-2, indicating that @PROTEIN2$ uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p9","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of @PROTEIN1$, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p10","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of @PROTEIN1$, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d136.s1154.p11","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and @PROTEIN1$ competed for binding with @PROTEIN2$, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p12","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and @PROTEIN1$ competed for binding with IL-2, indicating that @PROTEIN2$ uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p13","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and @PROTEIN1$ competed for binding with IL-2, indicating that IL-15 uses components of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p14","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and @PROTEIN1$ competed for binding with IL-2, indicating that IL-15 uses components of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d136.s1154.p15","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with @PROTEIN1$, indicating that @PROTEIN2$ uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p16","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with @PROTEIN1$, indicating that IL-15 uses components of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p17","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with @PROTEIN1$, indicating that IL-15 uses components of the @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d136.s1154.p18","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that @PROTEIN1$ uses components of the @PROTEIN2$ receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p19","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that @PROTEIN1$ uses components of the @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d136.s1154.p20","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the @PROTEIN1$@PROTEIN2$.","label":0}
{"pair_id":"AIMed.d165.s1391.p0","sentence":"Our analyses demonstrate that the @PROTEIN1$, @PROTEIN2$, p44, and p62 proteins interact with each other.","label":1}
{"pair_id":"AIMed.d165.s1391.p1","sentence":"Our analyses demonstrate that the @PROTEIN1$, XPD, @PROTEIN2$, and p62 proteins interact with each other.","label":0}
{"pair_id":"AIMed.d165.s1391.p2","sentence":"Our analyses demonstrate that the @PROTEIN1$, XPD, p44, and @PROTEIN2$ proteins interact with each other.","label":0}
{"pair_id":"AIMed.d165.s1391.p3","sentence":"Our analyses demonstrate that the XPB, @PROTEIN1$, @PROTEIN2$, and p62 proteins interact with each other.","label":0}
{"pair_id":"AIMed.d165.s1391.p4","sentence":"Our analyses demonstrate that the XPB, @PROTEIN1$, p44, and @PROTEIN2$ proteins interact with each other.","label":0}
{"pair_id":"AIMed.d165.s1391.p5","sentence":"Our analyses demonstrate that the XPB, XPD, @PROTEIN1$, and @PROTEIN2$ proteins interact with each other.","label":0}
{"pair_id":"BioInfer.d58.s0.p0","sentence":"Analysis of the u.v. absorbance and far-u.v. circular dichroism spectra of @PROTEIN1$ and @PROTEIN2$ did not reveal any major changes in the conformation of the proteins accompanying the modifications at the C-terminal ends.","label":0}
{"pair_id":"AIMed.d79.s681.p0","sentence":"While the function of @PROTEIN1$ is not yet clear, its structure and pattern of expression suggest a role for @PROTEIN2$ in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma.","label":0}
{"pair_id":"AIMed.d85.s718.p0","sentence":"In the second of a series of experiments designed to identify @PROTEIN1$-Src homology 3 (SH3)-binding molecules, we report the cloning of @PROTEIN2$ (Src A box Nck-associated protein II) from an HL60 cDNA expression library.","label":0}
{"pair_id":"AIMed.d85.s718.p1","sentence":"In the second of a series of experiments designed to identify @PROTEIN1$-Src homology 3 (SH3)-binding molecules, we report the cloning of SAKAP II (@PROTEIN2$) from an HL60 cDNA expression library.","label":0}
{"pair_id":"AIMed.d85.s718.p2","sentence":"In the second of a series of experiments designed to identify p47nck-Src homology 3 (SH3)-binding molecules, we report the cloning of @PROTEIN1$ (@PROTEIN2$) from an HL60 cDNA expression library.","label":0}
{"pair_id":"AIMed.d53.s471.p0","sentence":"Unlike human @PROTEIN1$ (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact @PROTEIN2$, which enhances the complementarity of the viral IL-6-gp130 binding interfaces.","label":1}
{"pair_id":"AIMed.d53.s471.p1","sentence":"Unlike human @PROTEIN1$ (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral @PROTEIN2$-gp130 binding interfaces.","label":0}
{"pair_id":"AIMed.d53.s471.p2","sentence":"Unlike human @PROTEIN1$ (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral IL-6-@PROTEIN2$ binding interfaces.","label":0}
{"pair_id":"AIMed.d53.s471.p3","sentence":"Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact @PROTEIN1$, which enhances the complementarity of the viral @PROTEIN2$-gp130 binding interfaces.","label":0}
{"pair_id":"AIMed.d53.s471.p4","sentence":"Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact @PROTEIN1$, which enhances the complementarity of the viral IL-6-@PROTEIN2$ binding interfaces.","label":0}
{"pair_id":"AIMed.d53.s471.p5","sentence":"Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral @PROTEIN1$-@PROTEIN2$ binding interfaces.","label":1}
{"pair_id":"BioInfer.d495.s0.p0","sentence":"Profilin I and @PROTEIN2$ have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric @PROTEIN1$ to the same extent.","label":1}
{"pair_id":"BioInfer.d495.s0.p1","sentence":"@PROTEIN2$ and profilin II have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric @PROTEIN1$ to the same extent.","label":1}
{"pair_id":"BioInfer.d495.s0.p2","sentence":"@PROTEIN2$ and @PROTEIN1$ have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric actin to the same extent.","label":1}
{"pair_id":"AIMed.d12.s103.p0","sentence":"RESULTS: In the blister fluid of patients with TEN, we found significantly higher levels of @PROTEIN1$ than in patients with burns, whereas @PROTEIN2$ levels were higher in the blister fluid of burned patients.","label":0}
{"pair_id":"BioInfer.d433.s0.p0","sentence":"Monoclonal antibodies recognizing the N- and C-terminal regions of @PROTEIN1$ disrupt @PROTEIN2$ stress fibers when microinjected into human fibroblasts.","label":1}
{"pair_id":"AIMed.d57.s508.p0","sentence":"The native and reconstituted @PROTEIN1$-@PROTEIN2$ complexes have similar thermal stability and, like steroid receptor heterocomplexes, they are stabilized by molybdate.","label":1}
{"pair_id":"BioInfer.d269.s0.p0","sentence":"However, immunofluorescence staining revealed a similar organisation of @PROTEIN2$ microfilaments, @PROTEIN1$ and phosphotyrosyl-containing proteins on both substrates.","label":0}
{"pair_id":"BioInfer.d5.s2.p0","sentence":"Since the NH2 terminus of @PROTEIN1$ is blocked, Edman degradation gave only the sequence of the conjugated @PROTEIN2$ CNBr fragment beginning with Trp-356.","label":0}
{"pair_id":"AIMed.d118.s996.p0","sentence":"The @PROTEIN1$ inhibitor of cyclin-dependent kinases controls DNA replication by interaction with @PROTEIN2$.","label":1}
{"pair_id":"AIMed.d169.s1430.p0","sentence":"The @PROTEIN1$ shows homology with the @PROTEIN2$ receptor, and to a lesser extent, with the prolactin receptor.","label":0}
{"pair_id":"AIMed.d165.s1392.p0","sentence":"@PROTEIN1$ protein interacts with multiple subunits of @PROTEIN2$ and with CSB protein.","label":0}
{"pair_id":"AIMed.d165.s1392.p1","sentence":"@PROTEIN1$ protein interacts with multiple subunits of TFIIH and with @PROTEIN2$ protein.","label":1}
{"pair_id":"AIMed.d165.s1392.p2","sentence":"XPG protein interacts with multiple subunits of @PROTEIN1$ and with @PROTEIN2$ protein.","label":0}
{"pair_id":"BioInfer.d746.s0.p0","sentence":"This shows that structural changes in the poly(L-proline)-binding region of @PROTEIN2$ can affect the distantly located @PROTEIN1$-binding site.","label":1}
{"pair_id":"BioInfer.d819.s0.p0","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the @PROTEIN1$ and fimbrin from the cores but does not affect actin binding by 110-kD @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d819.s0.p1","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the @PROTEIN1$ and @PROTEIN2$ from the cores but does not affect actin binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p2","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the @PROTEIN1$ and fimbrin from the cores but does not affect @PROTEIN2$ binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p3","sentence":"We report here that @PROTEIN2$, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the @PROTEIN1$ and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.","label":1}
{"pair_id":"BioInfer.d819.s0.p4","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the @PROTEIN2$ of isolated cores, and can cause the dissociation of up to 30% of the @PROTEIN1$ and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p5","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and @PROTEIN2$ from the cores but does not affect actin binding by 110-kD @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d819.s0.p6","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect @PROTEIN2$ binding by 110-kD @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d819.s0.p7","sentence":"We report here that @PROTEIN2$, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d819.s0.p8","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the @PROTEIN2$ of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d819.s0.p9","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and @PROTEIN1$ from the cores but does not affect @PROTEIN2$ binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p10","sentence":"We report here that @PROTEIN2$, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and @PROTEIN1$ from the cores but does not affect actin binding by 110-kD calmodulin.","label":1}
{"pair_id":"BioInfer.d819.s0.p11","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the @PROTEIN2$ of isolated cores, and can cause the dissociation of up to 30% of the villin and @PROTEIN1$ from the cores but does not affect actin binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p12","sentence":"We report here that @PROTEIN2$, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect @PROTEIN1$ binding by 110-kD calmodulin.","label":1}
{"pair_id":"BioInfer.d819.s0.p13","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the @PROTEIN2$ of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect @PROTEIN1$ binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p14","sentence":"We report here that @PROTEIN1$, which is found in the rootlet but not in the microvillus core, can bind to and saturate the @PROTEIN2$ of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.","label":1}
{"pair_id":"BioInfer.d71.s0.p0","sentence":"@PROTEIN2$, @PROTEIN1$, and RAD54 encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.","label":0}
{"pair_id":"BioInfer.d71.s0.p1","sentence":"RAD51, @PROTEIN1$, and @PROTEIN2$ encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.","label":0}
{"pair_id":"BioInfer.d71.s0.p2","sentence":"@PROTEIN1$, RAD52, and @PROTEIN2$ encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.","label":0}
{"pair_id":"BioInfer.d432.s1.p0","sentence":"Other @PROTEIN2$-associated proteins, including @PROTEIN1$, talin, and ezrin, are not present.","label":1}
{"pair_id":"BioInfer.d432.s1.p1","sentence":"Other actin-associated proteins, including @PROTEIN1$, talin, and @PROTEIN2$, are not present.","label":0}
{"pair_id":"BioInfer.d432.s1.p2","sentence":"Other actin-associated proteins, including @PROTEIN1$, @PROTEIN2$, and ezrin, are not present.","label":0}
{"pair_id":"BioInfer.d432.s1.p3","sentence":"Other @PROTEIN1$-associated proteins, including vinculin, talin, and @PROTEIN2$, are not present.","label":1}
{"pair_id":"BioInfer.d432.s1.p4","sentence":"Other @PROTEIN1$-associated proteins, including vinculin, @PROTEIN2$, and ezrin, are not present.","label":1}
{"pair_id":"BioInfer.d432.s1.p5","sentence":"Other actin-associated proteins, including vinculin, @PROTEIN2$, and @PROTEIN1$, are not present.","label":0}
{"pair_id":"AIMed.d87.s734.p0","sentence":"Interaction of the @PROTEIN1$ subunit of @PROTEIN2$ with the insulin receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p1","sentence":"Interaction of the @PROTEIN1$ subunit of PI 3-kinase with the @PROTEIN2$ receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p2","sentence":"Interaction of the @PROTEIN1$ subunit of PI 3-kinase with the @PROTEIN2$ (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p3","sentence":"Interaction of the @PROTEIN1$ subunit of PI 3-kinase with the insulin receptor (@PROTEIN2$) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p4","sentence":"Interaction of the @PROTEIN1$ subunit of PI 3-kinase with the insulin receptor (IR) and the @PROTEIN2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p5","sentence":"Interaction of the @PROTEIN1$ subunit of PI 3-kinase with the insulin receptor (IR) and the @PROTEIN2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p6","sentence":"Interaction of the @PROTEIN1$ subunit of PI 3-kinase with the insulin receptor (IR) and the IGF-1 receptor (@PROTEIN2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p7","sentence":"Interaction of the p85 subunit of @PROTEIN1$ with the @PROTEIN2$ receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p8","sentence":"Interaction of the p85 subunit of @PROTEIN1$ with the @PROTEIN2$ (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":1}
{"pair_id":"AIMed.d87.s734.p9","sentence":"Interaction of the p85 subunit of @PROTEIN1$ with the insulin receptor (@PROTEIN2$) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":1}
{"pair_id":"AIMed.d87.s734.p10","sentence":"Interaction of the p85 subunit of @PROTEIN1$ with the insulin receptor (IR) and the @PROTEIN2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p11","sentence":"Interaction of the p85 subunit of @PROTEIN1$ with the insulin receptor (IR) and the @PROTEIN2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":1}
{"pair_id":"AIMed.d87.s734.p12","sentence":"Interaction of the p85 subunit of @PROTEIN1$ with the insulin receptor (IR) and the IGF-1 receptor (@PROTEIN2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":1}
{"pair_id":"AIMed.d87.s734.p13","sentence":"Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN1$@PROTEIN2$ (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p14","sentence":"Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN1$ receptor (@PROTEIN2$) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p15","sentence":"Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN1$ receptor (IR) and the @PROTEIN2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p16","sentence":"Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN1$ receptor (IR) and the @PROTEIN2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p17","sentence":"Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN1$ receptor (IR) and the IGF-1 receptor (@PROTEIN2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p18","sentence":"Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN1$ (@PROTEIN2$) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p19","sentence":"Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN1$ (IR) and the @PROTEIN2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p20","sentence":"Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN1$ (IR) and the @PROTEIN2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p21","sentence":"Interaction of the p85 subunit of PI 3-kinase with the @PROTEIN1$ (IR) and the IGF-1 receptor (@PROTEIN2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p22","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (@PROTEIN1$) and the @PROTEIN2$ receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p23","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (@PROTEIN1$) and the @PROTEIN2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p24","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (@PROTEIN1$) and the IGF-1 receptor (@PROTEIN2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p25","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the @PROTEIN1$@PROTEIN2$ (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p26","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the @PROTEIN1$ receptor (@PROTEIN2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p27","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the @PROTEIN1$ (@PROTEIN2$) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"BioInfer.d112.s0.p0","sentence":"Both types of beads induced the recruitment of @PROTEIN1$, beta-catenin, @PROTEIN2$ and p120, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p1","sentence":"Both types of beads induced the recruitment of @PROTEIN1$, @PROTEIN2$, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p2","sentence":"Both types of beads induced the recruitment of @PROTEIN1$, beta-catenin, alpha-catenin and @PROTEIN2$, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p3","sentence":"Both types of beads induced the recruitment of N-cadherin, @PROTEIN2$, @PROTEIN1$ and p120, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p4","sentence":"Both types of beads induced the recruitment of N-cadherin, beta-catenin, @PROTEIN1$ and @PROTEIN2$, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p5","sentence":"Both types of beads induced the recruitment of N-cadherin, @PROTEIN1$, alpha-catenin and @PROTEIN2$, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d535.s0.p0","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified @PROTEIN2$ without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native @PROTEIN1$; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p1","sentence":"Several lines of evidence show that the @PROTEIN2$ fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native @PROTEIN1$; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p2","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to @PROTEIN2$ in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native @PROTEIN1$; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p3","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed @PROTEIN2$ form 3-D crystals under the same conditions as native @PROTEIN1$; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p4","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native @PROTEIN1$; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native @PROTEIN2$; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p5","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native @PROTEIN1$; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba @PROTEIN2$ inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p6","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native @PROTEIN1$; 3) dialyzed Acanthamoeba @PROTEIN2$ has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p7","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human @PROTEIN2$ rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native @PROTEIN1$; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p8","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native @PROTEIN1$; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p9","sentence":"Several lines of evidence show that the @PROTEIN2$ fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified @PROTEIN1$ without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p10","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to @PROTEIN2$ in the same way as native, conventionally purified @PROTEIN1$ without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p11","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified @PROTEIN1$ without urea treatment; 2) dialyzed @PROTEIN2$ form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p12","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified @PROTEIN1$ without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native @PROTEIN2$; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p13","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified @PROTEIN1$ without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba @PROTEIN2$ inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p14","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified @PROTEIN1$ without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba @PROTEIN2$ has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p15","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human @PROTEIN2$ rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified @PROTEIN1$ without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p16","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified @PROTEIN1$ without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p17","sentence":"Several lines of evidence show that the @PROTEIN1$ fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to @PROTEIN2$ in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p18","sentence":"Several lines of evidence show that the @PROTEIN1$ fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed @PROTEIN2$ form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p19","sentence":"Several lines of evidence show that the @PROTEIN1$ fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native @PROTEIN2$; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p20","sentence":"Several lines of evidence show that the @PROTEIN1$ fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba @PROTEIN2$ inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p21","sentence":"Several lines of evidence show that the @PROTEIN1$ fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba @PROTEIN2$ has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p22","sentence":"Several lines of evidence show that the @PROTEIN1$ fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human @PROTEIN2$ rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p23","sentence":"Several lines of evidence show that the @PROTEIN1$ fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p24","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to @PROTEIN1$ in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed @PROTEIN2$ form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p25","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to @PROTEIN1$ in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native @PROTEIN2$; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p26","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to @PROTEIN1$ in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba @PROTEIN2$ inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p27","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to @PROTEIN1$ in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba @PROTEIN2$ has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p28","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human @PROTEIN2$ rebind quantitatively to poly-L-proline and bind to @PROTEIN1$ in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p29","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to @PROTEIN1$ in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p30","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed @PROTEIN1$ form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native @PROTEIN2$; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p31","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed @PROTEIN1$ form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba @PROTEIN2$ inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p32","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed @PROTEIN1$ form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba @PROTEIN2$ has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p33","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human @PROTEIN2$ rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed @PROTEIN1$ form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p34","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed @PROTEIN1$ form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p35","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native @PROTEIN1$; and 4) dialyzed human and Acanthamoeba @PROTEIN2$ inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p36","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba @PROTEIN2$ has an NMR spectrum identical with that of native @PROTEIN1$; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p37","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human @PROTEIN2$ rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native @PROTEIN1$; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p38","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native @PROTEIN1$; and 4) dialyzed human and Acanthamoeba profilins inhibit @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p39","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba @PROTEIN2$ has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba @PROTEIN1$ inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p40","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human @PROTEIN2$ rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba @PROTEIN1$ inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p41","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba @PROTEIN1$ inhibit @PROTEIN2$ polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p42","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human @PROTEIN2$ rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba @PROTEIN1$ has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p43","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba @PROTEIN1$ has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit @PROTEIN2$ polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p44","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human @PROTEIN1$ rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit @PROTEIN2$ polymerization.","label":0}
{"pair_id":"AIMed.d176.s1493.p0","sentence":"The interactions of @PROTEIN1$ and @PROTEIN2$ in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).","label":1}
{"pair_id":"AIMed.d176.s1493.p1","sentence":"The interactions of @PROTEIN1$ and hsp90 in intermediate @PROTEIN2$ complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p2","sentence":"The interactions of @PROTEIN1$ and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early @PROTEIN2$ complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p3","sentence":"The interactions of @PROTEIN1$ and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (@PROTEIN2$) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p4","sentence":"The interactions of @PROTEIN1$ and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature @PROTEIN2$ complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p5","sentence":"The interactions of hsp70 and @PROTEIN1$ in intermediate @PROTEIN2$ complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p6","sentence":"The interactions of hsp70 and @PROTEIN1$ in intermediate PR complexes are shown to be distinct from their separate interactions in early @PROTEIN2$ complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p7","sentence":"The interactions of hsp70 and @PROTEIN1$ in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (@PROTEIN2$) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p8","sentence":"The interactions of hsp70 and @PROTEIN1$ in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature @PROTEIN2$ complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p9","sentence":"The interactions of hsp70 and hsp90 in intermediate @PROTEIN1$ complexes are shown to be distinct from their separate interactions in early @PROTEIN2$ complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p10","sentence":"The interactions of hsp70 and hsp90 in intermediate @PROTEIN1$ complexes are shown to be distinct from their separate interactions in early PR complexes (@PROTEIN2$) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p11","sentence":"The interactions of hsp70 and hsp90 in intermediate @PROTEIN1$ complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature @PROTEIN2$ complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p12","sentence":"The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early @PROTEIN1$ complexes (@PROTEIN2$) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p13","sentence":"The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early @PROTEIN1$ complexes (hsp70) or in mature @PROTEIN2$ complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p14","sentence":"The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (@PROTEIN1$) or in mature @PROTEIN2$ complexes (hsp90).","label":0}
{"pair_id":"AIMed.d190.s1620.p0","sentence":"Taken together our results demonstrate that @PROTEIN1$ plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with @PROTEIN2$\/c-Cbl complex when non-tyrosine or tyrosine kinase receptors are activated.","label":0}
{"pair_id":"AIMed.d190.s1620.p1","sentence":"Taken together our results demonstrate that @PROTEIN1$ plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with Grb2\/@PROTEIN2$ complex when non-tyrosine or tyrosine kinase receptors are activated.","label":0}
{"pair_id":"AIMed.d190.s1620.p2","sentence":"Taken together our results demonstrate that c-Cbl plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with @PROTEIN1$\/@PROTEIN2$ complex when non-tyrosine or tyrosine kinase receptors are activated.","label":1}
{"pair_id":"BioInfer.d579.s0.p0","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, @PROTEIN1$, and @PROTEIN2$, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p1","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, @PROTEIN2$, UL52, @PROTEIN1$, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p2","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, @PROTEIN2$, @PROTEIN1$, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p3","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, @PROTEIN2$, UL9, UL42, UL52, @PROTEIN1$, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p4","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, @PROTEIN2$, UL42, UL52, @PROTEIN1$, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p5","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, @PROTEIN2$, UL8, UL9, UL42, UL52, @PROTEIN1$, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p6","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, @PROTEIN2$, UL52, SSB, and @PROTEIN1$, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p7","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, @PROTEIN2$, SSB, and @PROTEIN1$, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p8","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, @PROTEIN2$, UL9, UL42, UL52, SSB, and @PROTEIN1$, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p9","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, @PROTEIN2$, UL42, UL52, SSB, and @PROTEIN1$, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p10","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, @PROTEIN2$, UL8, UL9, UL42, UL52, SSB, and @PROTEIN1$, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p11","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, @PROTEIN1$, @PROTEIN2$, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p12","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, @PROTEIN2$, UL9, @PROTEIN1$, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p13","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, @PROTEIN2$, @PROTEIN1$, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p14","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, @PROTEIN2$, UL8, UL9, @PROTEIN1$, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p15","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, @PROTEIN2$, UL9, UL42, @PROTEIN1$, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p16","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, @PROTEIN2$, UL42, @PROTEIN1$, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p17","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, @PROTEIN2$, UL8, UL9, UL42, @PROTEIN1$, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p18","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, @PROTEIN1$, @PROTEIN2$, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p19","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, @PROTEIN2$, @PROTEIN1$, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p20","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, @PROTEIN2$, UL8, @PROTEIN1$, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d765.s0.p0","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (@PROTEIN2$) @PROTEIN1$ and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":1}
{"pair_id":"BioInfer.d765.s0.p1","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the @PROTEIN2$ (CKIs) @PROTEIN1$ and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":1}
{"pair_id":"BioInfer.d765.s0.p2","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, @PROTEIN2$, the cyclin-dependent kinase inhibitors (CKIs) @PROTEIN1$ and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p3","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of @PROTEIN2$, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) @PROTEIN1$ and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p4","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, @PROTEIN2$, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) @PROTEIN1$ and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p5","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) @PROTEIN1$ and @PROTEIN2$, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p6","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the @PROTEIN2$ (@PROTEIN1$) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p7","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, @PROTEIN2$, the cyclin-dependent kinase inhibitors (@PROTEIN1$) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p8","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of @PROTEIN2$, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (@PROTEIN1$) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p9","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, @PROTEIN2$, cyclin D1, the cyclin-dependent kinase inhibitors (@PROTEIN1$) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p10","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (@PROTEIN1$) p27 and @PROTEIN2$, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":1}
{"pair_id":"BioInfer.d765.s0.p11","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, @PROTEIN2$, the @PROTEIN1$ (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p12","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of @PROTEIN2$, cyclin B1, cyclin D1, the @PROTEIN1$ (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p13","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, @PROTEIN2$, cyclin D1, the @PROTEIN1$ (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p14","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the @PROTEIN1$ (CKIs) p27 and @PROTEIN2$, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":1}
{"pair_id":"BioInfer.d765.s0.p15","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of @PROTEIN2$, cyclin B1, @PROTEIN1$, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p16","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, @PROTEIN2$, @PROTEIN1$, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p17","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, @PROTEIN1$, the cyclin-dependent kinase inhibitors (CKIs) p27 and @PROTEIN2$, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p18","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of @PROTEIN1$, @PROTEIN2$, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p19","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of @PROTEIN1$, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and @PROTEIN2$, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p20","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, @PROTEIN1$, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and @PROTEIN2$, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"AIMed.d144.s1220.p0","sentence":"In vitro-binding assays demonstrated that @PROTEIN1$ isoforms preferentially bind the hypophosphorylated form of @PROTEIN2$.","label":1}
{"pair_id":"BioInfer.d772.s0.p0","sentence":"Transcriptional expression of TNFR1(p55), as well as that of @PROTEIN1$, Fas, FADD, DR3, FAF, @PROTEIN2$, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p1","sentence":"Transcriptional expression of TNFR1(p55), as well as that of @PROTEIN1$, Fas, @PROTEIN2$, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p2","sentence":"Transcriptional expression of TNFR1(p55), as well as that of @PROTEIN1$, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to @PROTEIN2$-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p3","sentence":"Transcriptional expression of TNFR1(p55), as well as that of @PROTEIN1$, Fas, FADD, DR3, @PROTEIN2$, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p4","sentence":"Transcriptional expression of @PROTEIN2$(p55), as well as that of @PROTEIN1$, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p5","sentence":"Transcriptional expression of TNFR1(p55), as well as that of @PROTEIN1$, Fas, FADD, @PROTEIN2$, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p6","sentence":"Transcriptional expression of TNFR1(p55), as well as that of @PROTEIN1$, @PROTEIN2$, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p7","sentence":"Transcriptional expression of TNFR1(@PROTEIN2$), as well as that of @PROTEIN1$, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p8","sentence":"Transcriptional expression of TNFR1(p55), as well as that of @PROTEIN1$, Fas, FADD, DR3, FAF, TRADD, and @PROTEIN2$ was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p9","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, @PROTEIN2$, DR3, FAF, @PROTEIN1$, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p10","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, @PROTEIN1$, and RIP was similar in these cell lines, indicating that the susceptibility to @PROTEIN2$-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p11","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, @PROTEIN2$, @PROTEIN1$, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p12","sentence":"Transcriptional expression of @PROTEIN2$(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, @PROTEIN1$, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p13","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, @PROTEIN2$, FAF, @PROTEIN1$, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p14","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, @PROTEIN2$, FADD, DR3, FAF, @PROTEIN1$, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p15","sentence":"Transcriptional expression of TNFR1(@PROTEIN2$), as well as that of FLICE, Fas, FADD, DR3, FAF, @PROTEIN1$, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p16","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, @PROTEIN1$, and @PROTEIN2$ was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p17","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, @PROTEIN1$, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to @PROTEIN2$-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p18","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, @PROTEIN1$, DR3, @PROTEIN2$, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p19","sentence":"Transcriptional expression of @PROTEIN2$(p55), as well as that of FLICE, Fas, @PROTEIN1$, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p20","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, @PROTEIN1$, @PROTEIN2$, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p21","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, @PROTEIN2$, @PROTEIN1$, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p22","sentence":"Transcriptional expression of TNFR1(@PROTEIN2$), as well as that of FLICE, Fas, @PROTEIN1$, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p23","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, @PROTEIN1$, DR3, FAF, TRADD, and @PROTEIN2$ was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p24","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, @PROTEIN2$, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to @PROTEIN1$-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p25","sentence":"Transcriptional expression of @PROTEIN2$(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to @PROTEIN1$-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p26","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, @PROTEIN2$, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to @PROTEIN1$-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p27","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, @PROTEIN2$, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to @PROTEIN1$-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p28","sentence":"Transcriptional expression of TNFR1(@PROTEIN2$), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to @PROTEIN1$-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p29","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and @PROTEIN2$ was similar in these cell lines, indicating that the susceptibility to @PROTEIN1$-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p30","sentence":"Transcriptional expression of @PROTEIN2$(p55), as well as that of FLICE, Fas, FADD, DR3, @PROTEIN1$, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p31","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, @PROTEIN2$, @PROTEIN1$, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p32","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, @PROTEIN2$, FADD, DR3, @PROTEIN1$, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p33","sentence":"Transcriptional expression of TNFR1(@PROTEIN2$), as well as that of FLICE, Fas, FADD, DR3, @PROTEIN1$, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p34","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, @PROTEIN1$, TRADD, and @PROTEIN2$ was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p35","sentence":"Transcriptional expression of @PROTEIN1$(p55), as well as that of FLICE, Fas, FADD, @PROTEIN2$, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p36","sentence":"Transcriptional expression of @PROTEIN1$(p55), as well as that of FLICE, @PROTEIN2$, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p37","sentence":"Transcriptional expression of @PROTEIN1$(@PROTEIN2$), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p38","sentence":"Transcriptional expression of @PROTEIN1$(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and @PROTEIN2$ was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p39","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, @PROTEIN2$, FADD, @PROTEIN1$, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p40","sentence":"Transcriptional expression of TNFR1(@PROTEIN2$), as well as that of FLICE, Fas, FADD, @PROTEIN1$, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p41","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, @PROTEIN1$, FAF, TRADD, and @PROTEIN2$ was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p42","sentence":"Transcriptional expression of TNFR1(@PROTEIN2$), as well as that of FLICE, @PROTEIN1$, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p43","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, @PROTEIN1$, FADD, DR3, FAF, TRADD, and @PROTEIN2$ was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p44","sentence":"Transcriptional expression of TNFR1(@PROTEIN1$), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and @PROTEIN2$ was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d560.s0.p0","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN2$ (P), @PROTEIN1$, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p1","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (M), @PROTEIN2$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p2","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (M), fusion protein (F), @PROTEIN2$ (SH) @PROTEIN2$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p3","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN2$ (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p4","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN2$ (L) @PROTEIN2$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p5","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (@PROTEIN2$), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p6","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN2$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p7","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN2$), phosphoprotein (P), @PROTEIN1$, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p8","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, @PROTEIN2$ (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p9","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN2$ (HN) @PROTEIN2$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p10","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$), @PROTEIN1$, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p11","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (M), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p12","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (M), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p13","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), @PROTEIN1$, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p14","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, matrix protein (M), @PROTEIN2$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p15","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, matrix protein (M), fusion protein (F), @PROTEIN2$ (SH) @PROTEIN2$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p16","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN2$ (NP), @PROTEIN1$ (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p17","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN2$ (L) @PROTEIN2$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p18","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, matrix protein (@PROTEIN2$), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p19","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN2$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p20","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN2$), @PROTEIN1$ (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p21","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, @PROTEIN2$ (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p22","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN2$ (HN) @PROTEIN2$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p23","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (@PROTEIN2$), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p24","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p25","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, matrix protein (M), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p26","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), @PROTEIN1$ (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p27","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), @PROTEIN1$ (F), @PROTEIN2$ (SH) @PROTEIN2$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p28","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN2$ (NP), phosphoprotein (P), V protein, matrix protein (M), @PROTEIN1$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p29","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), @PROTEIN1$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN2$ (L) @PROTEIN2$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p30","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (@PROTEIN2$), @PROTEIN1$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p31","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), @PROTEIN1$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN2$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p32","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN2$), phosphoprotein (P), V protein, matrix protein (M), @PROTEIN1$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p33","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, @PROTEIN2$ (M), @PROTEIN1$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p34","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), @PROTEIN1$ (F), small hydrophobic (SH) small h, @PROTEIN2$ (HN) @PROTEIN2$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p35","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$), V protein, matrix protein (M), @PROTEIN1$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p36","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), @PROTEIN1$ (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p37","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), @PROTEIN1$ (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p38","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), @PROTEIN1$ (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p39","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN2$ (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), @PROTEIN1$ (SH) @PROTEIN1$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p40","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), @PROTEIN1$ (SH) @PROTEIN1$, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN2$ (L) @PROTEIN2$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p41","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (@PROTEIN2$), fusion protein (F), @PROTEIN1$ (SH) @PROTEIN1$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p42","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), @PROTEIN1$ (SH) @PROTEIN1$, haemagglutinin-neuraminidase (@PROTEIN2$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p43","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN2$), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), @PROTEIN1$ (SH) @PROTEIN1$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p44","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, @PROTEIN2$ (M), fusion protein (F), @PROTEIN1$ (SH) @PROTEIN1$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p45","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), @PROTEIN1$ (SH) @PROTEIN1$, @PROTEIN2$ (HN) @PROTEIN2$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p46","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$), V protein, matrix protein (M), fusion protein (F), @PROTEIN1$ (SH) @PROTEIN1$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p47","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), @PROTEIN1$ (@PROTEIN2$) @PROTEIN1$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p48","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (@PROTEIN2$), @PROTEIN1$ (SH) @PROTEIN1$, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p49","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), @PROTEIN1$ (SH) @PROTEIN1$, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p50","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN2$ (L) @PROTEIN2$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p51","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (NP), phosphoprotein (P), V protein, matrix protein (@PROTEIN2$), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p52","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN2$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p53","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (@PROTEIN2$), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p54","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (NP), phosphoprotein (P), V protein, @PROTEIN2$ (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p55","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN2$ (HN) @PROTEIN2$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p56","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (NP), phosphoprotein (@PROTEIN2$), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p57","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p58","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p59","sentence":"The 16236 nt genome encodes eight proteins, @PROTEIN1$ (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p60","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (@PROTEIN2$), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN1$ (L) @PROTEIN1$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p61","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN2$) haemagg and @PROTEIN1$ (L) @PROTEIN1$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p62","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN2$), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN1$ (L) @PROTEIN1$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p63","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, @PROTEIN2$ (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN1$ (L) @PROTEIN1$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p64","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN2$ (HN) @PROTEIN2$ and @PROTEIN1$ (L) @PROTEIN1$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p65","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN1$ (L) @PROTEIN1$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p66","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN1$ (L) @PROTEIN1$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p67","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN1$ (L) @PROTEIN1$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p68","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and @PROTEIN1$ (@PROTEIN2$) @PROTEIN1$, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p69","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (@PROTEIN1$), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN2$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p70","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN2$), phosphoprotein (P), V protein, matrix protein (@PROTEIN1$), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p71","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, @PROTEIN2$ (@PROTEIN1$), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p72","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (@PROTEIN1$), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN2$ (HN) @PROTEIN2$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p73","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$), V protein, matrix protein (@PROTEIN1$), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p74","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (@PROTEIN1$), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p75","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (@PROTEIN1$), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p76","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (@PROTEIN1$), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p77","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN2$), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN1$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p78","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, @PROTEIN2$ (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN1$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p79","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN2$ (@PROTEIN1$) @PROTEIN2$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p80","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN1$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p81","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (@PROTEIN1$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p82","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN1$) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p83","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (@PROTEIN1$) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p84","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN1$), phosphoprotein (P), V protein, @PROTEIN2$ (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p85","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN1$), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN2$ (HN) @PROTEIN2$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p86","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN1$), phosphoprotein (@PROTEIN2$), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p87","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN1$), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p88","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN1$), phosphoprotein (P), V protein, matrix protein (M), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p89","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (@PROTEIN1$), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p90","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, @PROTEIN1$ (M), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN2$ (HN) @PROTEIN2$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p91","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$), V protein, @PROTEIN1$ (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p92","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, @PROTEIN1$ (M), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p93","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, @PROTEIN1$ (M), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p94","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, @PROTEIN1$ (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p95","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN2$), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN1$ (HN) @PROTEIN1$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p96","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, @PROTEIN1$ (HN) @PROTEIN1$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p97","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, @PROTEIN1$ (HN) @PROTEIN1$ and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p98","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, @PROTEIN1$ (HN) @PROTEIN1$ and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p99","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN1$), V protein, matrix protein (M), fusion protein (F), small hydrophobic (@PROTEIN2$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p100","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN1$), V protein, matrix protein (M), fusion protein (@PROTEIN2$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p101","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (@PROTEIN1$), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p102","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (@PROTEIN2$), small hydrophobic (@PROTEIN1$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p103","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (@PROTEIN1$) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p104","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (@PROTEIN1$), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (@PROTEIN2$) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d175.s1.p0","sentence":"The @PROTEIN2$, TIF34, @PROTEIN1$, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p1","sentence":"The PRT1, TIF34, @PROTEIN1$, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with @PROTEIN2$ (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p2","sentence":"The PRT1, @PROTEIN2$, @PROTEIN1$, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p3","sentence":"The PRT1, TIF34, @PROTEIN1$, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (@PROTEIN2$) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p4","sentence":"The PRT1, TIF34, @PROTEIN1$, and @PROTEIN2$ proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p5","sentence":"The @PROTEIN1$, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with @PROTEIN2$ (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p6","sentence":"The @PROTEIN1$, @PROTEIN2$, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p7","sentence":"The @PROTEIN1$, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (@PROTEIN2$) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p8","sentence":"The @PROTEIN1$, TIF34, GCD10, and @PROTEIN2$ proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p9","sentence":"The PRT1, @PROTEIN2$, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with @PROTEIN1$ (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p10","sentence":"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with @PROTEIN1$ (@PROTEIN2$) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p11","sentence":"The PRT1, TIF34, GCD10, and @PROTEIN2$ proteins of Saccharomyces cerevisiae were found previously to copurify with @PROTEIN1$ (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p12","sentence":"The PRT1, @PROTEIN1$, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (@PROTEIN2$) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p13","sentence":"The PRT1, @PROTEIN1$, GCD10, and @PROTEIN2$ proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p14","sentence":"The PRT1, TIF34, GCD10, and @PROTEIN2$ proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (@PROTEIN1$) activity.","label":0}
{"pair_id":"AIMed.d214.s1859.p0","sentence":"This suggests that @PROTEIN1$ may link @PROTEIN2$ activation to molecules that regulate GTP binding proteins.","label":0}
{"pair_id":"BioInfer.d18.s0.p0","sentence":"@PROTEIN1$ isoforms from different species were also compared, and the effect of profilin on the thermal stability of @PROTEIN2$ was studied.","label":0}
{"pair_id":"BioInfer.d18.s0.p1","sentence":"@PROTEIN1$ isoforms from different species were also compared, and the effect of @PROTEIN2$ on the thermal stability of actin was studied.","label":0}
{"pair_id":"BioInfer.d18.s0.p2","sentence":"Actin isoforms from different species were also compared, and the effect of @PROTEIN2$ on the thermal stability of @PROTEIN1$ was studied.","label":1}
{"pair_id":"BioInfer.d733.s0.p0","sentence":"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes @PROTEIN2$, RAD51, and @PROTEIN1$ for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p1","sentence":"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, @PROTEIN2$, and @PROTEIN1$ for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p2","sentence":"They exhibited strong synergistic increases in @PROTEIN2$ duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and @PROTEIN1$ for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p3","sentence":"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes @PROTEIN1$, @PROTEIN2$, and RAD52 for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p4","sentence":"They exhibited strong synergistic increases in @PROTEIN2$ duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes @PROTEIN1$, RAD51, and RAD52 for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p5","sentence":"They exhibited strong synergistic increases in @PROTEIN2$ duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, @PROTEIN1$, and RAD52 for viability.","label":0}
{"pair_id":"AIMed.d158.s1334.p0","sentence":"Here, we show that @PROTEIN1$ interacts strongly with @PROTEIN2$, another death domain protein that was shown previously to associate with Fas antigen.","label":1}
{"pair_id":"AIMed.d158.s1334.p1","sentence":"Here, we show that @PROTEIN1$ interacts strongly with RIP, another death domain protein that was shown previously to associate with @PROTEIN2$ antigen.","label":0}
{"pair_id":"AIMed.d158.s1334.p2","sentence":"Here, we show that TRADD interacts strongly with @PROTEIN1$, another death domain protein that was shown previously to associate with @PROTEIN2$ antigen.","label":1}
{"pair_id":"BioInfer.d381.s0.p0","sentence":"In this study we demonstrate that @PROTEIN1$ H3 and histone @PROTEIN2$ synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":0}
{"pair_id":"BioInfer.d381.s0.p1","sentence":"In this study we demonstrate that @PROTEIN1$ @PROTEIN2$ and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":1}
{"pair_id":"BioInfer.d381.s0.p2","sentence":"In this study we demonstrate that @PROTEIN1$ H3 and @PROTEIN2$ H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":0}
{"pair_id":"BioInfer.d381.s0.p3","sentence":"In this study we demonstrate that histone @PROTEIN2$ and histone @PROTEIN1$ synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":1}
{"pair_id":"BioInfer.d381.s0.p4","sentence":"In this study we demonstrate that histone H3 and @PROTEIN2$ @PROTEIN1$ synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":1}
{"pair_id":"BioInfer.d381.s0.p5","sentence":"In this study we demonstrate that histone @PROTEIN1$ and @PROTEIN2$ H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":0}
{"pair_id":"BioInfer.d607.s1.p0","sentence":"The previous investigation (Abe et al. (1989) J. Biochem. 106, 696-702) suggested that @PROTEIN2$ is deeply involved in the regulation of @PROTEIN1$ assembly in developing skeletal muscle.","label":1}
{"pair_id":"AIMed.d96.s811.p0","sentence":"In this article, we demonstrate that @PROTEIN1$ associates with a complex containing @PROTEIN2$- and beta-catenin in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.","label":0}
{"pair_id":"AIMed.d96.s811.p1","sentence":"In this article, we demonstrate that @PROTEIN1$ associates with a complex containing cadherins, alpha- and @PROTEIN2$ in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.","label":1}
{"pair_id":"AIMed.d96.s811.p2","sentence":"In this article, we demonstrate that PTPmu associates with a complex containing @PROTEIN1$- and @PROTEIN2$ in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.","label":0}
{"pair_id":"AIMed.d143.s1206.p0","sentence":"We have previously identified @PROTEIN1$ specific binding protein which is distinct from that of @PROTEIN2$ in a number of cell lines.","label":0}
{"pair_id":"AIMed.d74.s627.p0","sentence":"Two cDNA clones encoding a receptor for human @PROTEIN1$ (@PROTEIN2$) were isolated by expression screening of a library made from human placental mRNA.","label":1}
{"pair_id":"AIMed.d165.s1389.p0","sentence":"We have exploited the availability of the cloned @PROTEIN1$, @PROTEIN2$, p62, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p1","sentence":"We have exploited the availability of the cloned @PROTEIN1$, XPD, @PROTEIN2$, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p2","sentence":"We have exploited the availability of the cloned @PROTEIN1$, XPD, p62, @PROTEIN2$, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p3","sentence":"We have exploited the availability of the cloned @PROTEIN1$, XPD, p62, p44, and @PROTEIN2$ genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p4","sentence":"We have exploited the availability of the cloned @PROTEIN1$, XPD, p62, p44, and p34 genes (all of which encode polypeptide subunits of @PROTEIN2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p5","sentence":"We have exploited the availability of the cloned XPB, @PROTEIN1$, @PROTEIN2$, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p6","sentence":"We have exploited the availability of the cloned XPB, @PROTEIN1$, p62, @PROTEIN2$, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p7","sentence":"We have exploited the availability of the cloned XPB, @PROTEIN1$, p62, p44, and @PROTEIN2$ genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p8","sentence":"We have exploited the availability of the cloned XPB, @PROTEIN1$, p62, p44, and p34 genes (all of which encode polypeptide subunits of @PROTEIN2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p9","sentence":"We have exploited the availability of the cloned XPB, XPD, @PROTEIN1$, @PROTEIN2$, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p10","sentence":"We have exploited the availability of the cloned XPB, XPD, @PROTEIN1$, p44, and @PROTEIN2$ genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p11","sentence":"We have exploited the availability of the cloned XPB, XPD, @PROTEIN1$, p44, and p34 genes (all of which encode polypeptide subunits of @PROTEIN2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p12","sentence":"We have exploited the availability of the cloned XPB, XPD, p62, @PROTEIN1$, and @PROTEIN2$ genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p13","sentence":"We have exploited the availability of the cloned XPB, XPD, p62, @PROTEIN1$, and p34 genes (all of which encode polypeptide subunits of @PROTEIN2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p14","sentence":"We have exploited the availability of the cloned XPB, XPD, p62, p44, and @PROTEIN1$ genes (all of which encode polypeptide subunits of @PROTEIN2$) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"BioInfer.d260.s0.p0","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a @PROTEIN1$ that consists of three polypeptides encoded by the UL5, @PROTEIN2$, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":1}
{"pair_id":"BioInfer.d260.s0.p1","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a @PROTEIN1$ that consists of three polypeptides encoded by the @PROTEIN2$, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":1}
{"pair_id":"BioInfer.d260.s0.p2","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a @PROTEIN1$ that consists of three polypeptides encoded by the UL5, UL8, and @PROTEIN2$ genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":1}
{"pair_id":"BioInfer.d260.s0.p3","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the @PROTEIN2$, @PROTEIN1$, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":0}
{"pair_id":"BioInfer.d260.s0.p4","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, @PROTEIN1$, and @PROTEIN2$ genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":0}
{"pair_id":"BioInfer.d260.s0.p5","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the @PROTEIN1$, UL8, and @PROTEIN2$ genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":0}
{"pair_id":"BioInfer.d348.s2.p0","sentence":"These results suggest that the subcellular distribution of @PROTEIN2$ as well as its interaction with @PROTEIN1$ in vivo is regulated by its phosphorylation and dephosphorylation.","label":1}
{"pair_id":"AIMed.d76.s643.p0","sentence":"Further, anti-@PROTEIN1$ and anti-@PROTEIN2$ coprecipitated each other in a variety of detergents, including Nonidet P-40 and Triton X-100.","label":0}
{"pair_id":"AIMed.d161.s1358.p0","sentence":"We have localized the region of interaction to tyrosine 580 in the carboxyl end of @PROTEIN1$ and to the SH2 domain in the carboxy-terminus of @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d734.s0.p0","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of @PROTEIN1$ receptors, actin and cytoskeletal proteins such as vinculin and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d734.s0.p1","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of @PROTEIN1$ receptors, actin and cytoskeletal proteins such as @PROTEIN2$ and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p2","sentence":"They had altered adhesive properties as measured by their ability to bind to a @PROTEIN2$-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of @PROTEIN1$ receptors, actin and cytoskeletal proteins such as vinculin and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p3","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a @PROTEIN2$ alters the assembly of @PROTEIN1$ receptors, actin and cytoskeletal proteins such as vinculin and talin.","label":1}
{"pair_id":"BioInfer.d734.s0.p4","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of @PROTEIN1$ receptors, @PROTEIN2$ and cytoskeletal proteins such as vinculin and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p5","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as @PROTEIN2$ and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d734.s0.p6","sentence":"They had altered adhesive properties as measured by their ability to bind to a @PROTEIN2$-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d734.s0.p7","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a @PROTEIN2$ alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and @PROTEIN1$.","label":1}
{"pair_id":"BioInfer.d734.s0.p8","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, @PROTEIN2$ and cytoskeletal proteins such as vinculin and @PROTEIN1$.","label":0}
{"pair_id":"BioInfer.d734.s0.p9","sentence":"They had altered adhesive properties as measured by their ability to bind to a @PROTEIN2$-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as @PROTEIN1$ and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p10","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a @PROTEIN2$ alters the assembly of integrin receptors, actin and cytoskeletal proteins such as @PROTEIN1$ and talin.","label":1}
{"pair_id":"BioInfer.d734.s0.p11","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, @PROTEIN2$ and cytoskeletal proteins such as @PROTEIN1$ and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p12","sentence":"They had altered adhesive properties as measured by their ability to bind to a @PROTEIN1$-coated glass surface, suggesting that the expression of a @PROTEIN2$ alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p13","sentence":"They had altered adhesive properties as measured by their ability to bind to a @PROTEIN1$-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, @PROTEIN2$ and cytoskeletal proteins such as vinculin and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p14","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a @PROTEIN1$ alters the assembly of integrin receptors, @PROTEIN2$ and cytoskeletal proteins such as vinculin and talin.","label":1}
{"pair_id":"BioInfer.d616.s0.p0","sentence":"The genes considered are those for @PROTEIN2$, @PROTEIN1$ and 18S @PROTEIN1$@PROTEIN2$, actin I, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p1","sentence":"The genes considered are those for 5S, @PROTEIN1$ and @PROTEIN2$@PROTEIN1$, actin I, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p2","sentence":"The genes considered are those for 5S, @PROTEIN1$ and 18S @PROTEIN1$, actin I, @PROTEIN2$\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p3","sentence":"The genes considered are those for 5S, @PROTEIN1$ and 18S @PROTEIN1$, actin I, profilins Ia\/p and pr, @PROTEIN2$ IB, @PROTEIN2$ and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p4","sentence":"The genes considered are those for 5S, @PROTEIN1$ and 18S @PROTEIN1$, @PROTEIN2$, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p5","sentence":"The genes considered are those for 5S, @PROTEIN1$ and 18S @PROTEIN1$, actin I, @PROTEIN2$ Ia\/p and @PROTEIN2$, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p6","sentence":"The genes considered are those for 5S, @PROTEIN1$ and 18S @PROTEIN1$, actin I, profilins Ia\/p and pr, @PROTEIN2$ IB, my and @PROTEIN2$, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p7","sentence":"The genes considered are those for 5S, @PROTEIN1$ and 18S @PROTEIN1$, actin I, @PROTEIN2$a\/@PROTEIN2$ and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p8","sentence":"The genes considered are those for 5S, @PROTEIN1$ and 18S @PROTEIN1$, actin I, profilins Ia\/p and pr, @PROTEIN2$, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p9","sentence":"The genes considered are those for 5S, @PROTEIN1$ and 18S @PROTEIN1$, actin I, profilins Ia\/p and pr, myosins IB, my and my, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d616.s0.p10","sentence":"The genes considered are those for @PROTEIN1$, 5.8S and @PROTEIN2$@PROTEIN1$, actin I, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p11","sentence":"The genes considered are those for @PROTEIN1$, 5.8S and 18S @PROTEIN1$, actin I, @PROTEIN2$\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p12","sentence":"The genes considered are those for @PROTEIN1$, 5.8S and 18S @PROTEIN1$, actin I, profilins Ia\/p and pr, @PROTEIN2$ IB, @PROTEIN2$ and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p13","sentence":"The genes considered are those for @PROTEIN1$, 5.8S and 18S @PROTEIN1$, @PROTEIN2$, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p14","sentence":"The genes considered are those for @PROTEIN1$, 5.8S and 18S @PROTEIN1$, actin I, @PROTEIN2$ Ia\/p and @PROTEIN2$, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p15","sentence":"The genes considered are those for @PROTEIN1$, 5.8S and 18S @PROTEIN1$, actin I, profilins Ia\/p and pr, @PROTEIN2$ IB, my and @PROTEIN2$, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p16","sentence":"The genes considered are those for @PROTEIN1$, 5.8S and 18S @PROTEIN1$, actin I, @PROTEIN2$a\/@PROTEIN2$ and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p17","sentence":"The genes considered are those for @PROTEIN1$, 5.8S and 18S @PROTEIN1$, actin I, profilins Ia\/p and pr, @PROTEIN2$, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p18","sentence":"The genes considered are those for @PROTEIN1$, 5.8S and 18S @PROTEIN1$, actin I, profilins Ia\/p and pr, myosins IB, my and my, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d616.s0.p19","sentence":"The genes considered are those for 5S, 5.8S and @PROTEIN1$, actin I, @PROTEIN2$\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p20","sentence":"The genes considered are those for 5S, 5.8S and @PROTEIN1$, actin I, profilins Ia\/p and pr, @PROTEIN2$ IB, @PROTEIN2$ and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p21","sentence":"The genes considered are those for 5S, 5.8S and @PROTEIN1$, @PROTEIN2$, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p22","sentence":"The genes considered are those for 5S, 5.8S and @PROTEIN1$, actin I, @PROTEIN2$ Ia\/p and @PROTEIN2$, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p23","sentence":"The genes considered are those for 5S, 5.8S and @PROTEIN1$, actin I, profilins Ia\/p and pr, @PROTEIN2$ IB, my and @PROTEIN2$, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p24","sentence":"The genes considered are those for 5S, 5.8S and @PROTEIN1$, actin I, @PROTEIN2$a\/@PROTEIN2$ and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p25","sentence":"The genes considered are those for 5S, 5.8S and @PROTEIN1$, actin I, profilins Ia\/p and pr, @PROTEIN2$, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p26","sentence":"The genes considered are those for 5S, 5.8S and @PROTEIN1$, actin I, profilins Ia\/p and pr, myosins IB, my and my, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d616.s0.p27","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$\/p and pr, @PROTEIN2$ IB, @PROTEIN2$ and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p28","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, @PROTEIN2$, @PROTEIN1$\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p29","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$@PROTEIN2$ Ia\/p and @PROTEIN2$, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p30","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$\/p and pr, @PROTEIN2$ IB, my and @PROTEIN2$, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p31","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$@PROTEIN2$a\/@PROTEIN2$ and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p32","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$\/p and pr, @PROTEIN2$, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p33","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$\/p and pr, myosins IB, my and my, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d616.s0.p34","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, @PROTEIN2$, profilins Ia\/p and pr, @PROTEIN1$ IB, @PROTEIN1$ and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p35","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN2$ Ia\/p and @PROTEIN2$, @PROTEIN1$ IB, @PROTEIN1$ and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p36","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, @PROTEIN1$@PROTEIN2$ IB, @PROTEIN1$ and @PROTEIN2$, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p37","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN2$a\/@PROTEIN2$ and pr, @PROTEIN1$ IB, @PROTEIN1$ and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p38","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, @PROTEIN1$@PROTEIN2$, @PROTEIN1$ and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p39","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, @PROTEIN1$ IB, @PROTEIN1$ and my, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d616.s0.p40","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, @PROTEIN1$, @PROTEIN2$ Ia\/p and @PROTEIN2$, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p41","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, @PROTEIN1$, profilins Ia\/p and pr, @PROTEIN2$ IB, my and @PROTEIN2$, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p42","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, @PROTEIN1$, @PROTEIN2$a\/@PROTEIN2$ and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p43","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, @PROTEIN1$, profilins Ia\/p and pr, @PROTEIN2$, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p44","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, @PROTEIN1$, profilins Ia\/p and pr, myosins IB, my and my, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d616.s0.p45","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$ Ia\/p and @PROTEIN1$, @PROTEIN2$ IB, my and @PROTEIN2$, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p46","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$@PROTEIN2$a\/@PROTEIN2$ and @PROTEIN1$, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p47","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$ Ia\/p and @PROTEIN1$, @PROTEIN2$, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p48","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$ Ia\/p and @PROTEIN1$, myosins IB, my and my, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d616.s0.p49","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN2$a\/@PROTEIN2$ and pr, @PROTEIN1$ IB, my and @PROTEIN1$, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p50","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, @PROTEIN1$@PROTEIN2$, my and @PROTEIN1$, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p51","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, @PROTEIN1$ IB, my and @PROTEIN1$, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d616.s0.p52","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$a\/@PROTEIN1$ and pr, @PROTEIN2$, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p53","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, @PROTEIN1$a\/@PROTEIN1$ and pr, myosins IB, my and my, and @PROTEIN2$.","label":0}
{"pair_id":"BioInfer.d616.s0.p54","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, @PROTEIN1$, my and my, and @PROTEIN2$.","label":0}
{"pair_id":"AIMed.d47.s411.p0","sentence":"Crystal structure of the @PROTEIN1$-@PROTEIN2$ ectodomain complex.","label":1}